ML041190187
| ML041190187 | |
| Person / Time | |
|---|---|
| Site: | Fort Calhoun  |
| Issue date: | 12/31/2003 |
| From: | Omaha Public Power District |
| To: | Office of Nuclear Reactor Regulation |
| References | |
| Download: ML041190187 (92) | |
Text
Omaha Public Power District Fort Calhoun Station Unit No. 1 Annual Report For Technical Specification Section 5.9.4.a January 1, 2003 to December 31, 2003 DOCKET NO. 50-285 OPERATING LICENSE DPR-40
Omaha Public Power District Fort Calhoun Station Unit No. I Annual Report For Technical Specifications, Section 5.9.4.a January 1, 2003 to December 31, 2003
DOCKET NO. 50-285 OPERATING LICENSE DPR-40 Annual Radiological Effluent Release Report This report is submitted in accordance with Section 5.9.4.a of the Technical Specifications of Fort Calhoun Station Unit No. 1, Facility Operating License DPR-40 for the period January 1, 2003 through December 31, 2003. The Effluent Report is presented in the format outlined in Regulatory Guide 1.21, Revision 1.
In addition, this report provides the results of quarterly dose calculations performed in accordance with the Offsite Dose Calculation Manual.
Results are presented by quarter for the period January 1, 2003 through December 31, 2003.
Further description of any changes made during the preceding twelve months to the Offsite Dose Calculation Manual and/or the Process Control Program for the Fort Calhoun Station are presented.
MAR 2 4 2004 PRO MTG. MUAlUTES Manager-Fort Calhoun Station
TABLE OF CONTENTS Section Section Title I.
1.0 Introduction 1.1 Executive Summary 2.0 Supplemental Information 2.1 Regulatory Limits 2.2 Effluent Concentration Limits 2.3 Measurements and Approximations of Total Radioactivity 2.4 Estimation of Total Percent Error 2.5 Batch Releases 2.6 Abnormal Releases 3.0 Gaseous Effluents 4.0 Liquid Effluents 5.0 Solid Wastes 6.0 Related Information 6.1 Operability of Liquid and Gaseous Monitoring Instrumentation 6.2 Changes to Offsite Dose Calculation Manual (ODCM) or Process Control Program (PCP) 6.3 New Locations or Modifications for Dose Calculations or Environmental Monitoring 6.4 Noncompliance with Radiological Effluent Control Requirements 6.5 Modifications to Liquid and Gaseous Waste Treatment and Ventilation Exhaust Systems 6.6 Meteorological Monitoring Program 6.7 Assessment of Doses II.
Quarterly Doses from Effluents, Offsite Dose Calculation Manual
TABLE OF CONTENTS IIl.
Radiological Effluent Releases, Technical Specification (5.9.4.a)
Table 111.1; Batch Liquid and Gas Release Summary Table 111.2; Abnormal Batch Liquid and Gaseous Release Summary Table 111.3; Gaseous Effluents - Summation of All Releases Table 111.4; Gaseous Effluent Releases - Batch Mode Table 111.5; Gaseous Effluent Releases - Continuous Mode Table 111.6; Liquid Effluents - Summation of All Releases Table 111.7; Liquid Effluent Releases - Batch Mode Table 111.8; Liquid Effluent Releases - Continuous Mode IV.
Dose From Gaseous Effluents - GASPAR 11 Output Tables IV-A-1 through IV-A Receptor Dose Projections Table IV-B Dose Contributions at Unrestricted Area Boundary Table IV-C ALARA Annual Integrated Dose Summary V.
Dose From Liquid Effluents - LADTAP 11 Output Summary Dose Projections from Liquid Effluent Releases VI.
Radioactive Effluent Releases-Solid Radioactive Waste, Technical Specification (5.9.4.a)
VII.
ATTACHMENTS
- 1.
Joint Frequency Distribution Wind Direction vs. Wind Speed by Stability Class and Meteorological Data
- 2.
Annual Occupational Exposure Report, Technical Specification (5.9.1.b)
1.0 INTRODUCTION
This Annual Radiological Effluent Release Report, for Fort Calhoun Station Unit No. 1, is submitted as required by Technical Specification 5.9.4.a for the period January 1, 2003 through December 31, 2003.
1.1 Executive Summary The Radioactive Effluent Monitoring program for the year 2003 was conducted as described in the following report.
Major efforts were made to maintain the release of radioactive effluents to the environment as low as reasonably achievable. Activity released was significantly reduced due to the replacement of defective fuel in the spring of 2002.
The total gaseous activity released for 2003 was 19.2 Curies. This was less than 1% of-the 2259.8 Curies released in 2002.
Dose contributions from gaseous effluents at the unrestricted area boundary were 4.12E-03 millirad maximum gamma air dose, and 6.79E-03 millirad maximum beta air dose. This was a considerable decrease from the 2002 values of 2.20E-01 millirad and 7.12E-01 millirad respectively.
Total activity (excluding tritium, dissolved gases and alpha) released in 2003 in liquid effluents was.1.06E-01 Curies.
This was lower than the 2002 value of 4.20E-01 Curies.
The total tritium activity released in 2003 in liquid effluents was 295 Curies. This was a slight increase from the 2002 value of 293 Curies. -
The calculated whole body dose due to liquid effluents at the site discharge from all sources in 2003 was I.45E-02 mRem. This was a decrease from the 2002 dose of 1.69E-01 mRem. -
The calculated critical organ dose due to liquid effluents at the site discharge from all sources in 2003 was
- 1.51 E-03 mRem. -This was a decrease from the 2002 dose of 2.22E-01 mRem.
1-1
The Fort Calhoun Station meteorological system achieved a cumulative availability rate of 96.5% for the joint frequency parameters required by Regulatory Guide 1.23 of wind speed, wind direction and delta temperature.
There were no abnormal releases during 2003.
During 2003 there was one change to the Offsite Dose Calculations Manual (ODCM) and no changes to the Process Control Program (PCP).
For 2003; the total volume of buried solid radwaste was 16.66 cubic meters, this was a decrease from the 23.30 cubic meters of solid waste buried in 2002. The total buried activity for 2003 was 19.13 Curies, 17.6 of which came from spent resin. This was a decrease from the 2002 value of 952.76 Curies.
Overall, the radioactive effluent monitoring program was conducted in a manner to ensure the activity released and associated dose to the public were maintained as low as reasonably achievable.
2.0 SUPPLEMENTAL INFORMATION 2.1 Regulatorv Limits The ODCM Radiological Effluent Control Specifications applicable to the release of radioactive material in liquid and gaseous effluents are described in the following sections.
2.1.1 Fission and Activation Gases (Noble Gases)
The release rate of radioactive material in airborne effluents shall be controlled such that the instantaneous concentrations of radionuclides do not exceed the values specified in 10 CFR 20 for airborne effluents at the unrestricted area boundary. To support plant operations, Supervisor - System Chemistry may increase this limit up to the limits specified in Technical Specification 5.16.1.g.
Technical Specification 5.16.1.g establishes the administrative control limit on the concentration resulting from radioactive material, other than noble gases, released in gaseous effluents to unrestricted areas conforming to ten times 10 CFR 20.1001-20.2401, Appendix B, Table 2, 1-2
Column 1. For noble gases, the concentration shall be limited to five times 10 CFk 20.1001-20.2401, Appendix B, Table 2, Column 1.
The air dose due to noble gases released in gaseous effluents to areas at or beyond the unrestricted area boundary shall.be limited to the following:
- a.
During any calendar quarter: Less than or equal to 5 mrad for gamma radiation and less than or equal to 10 mrad for beta radiation, and
- b.
During any calendar year: Less than or equal to 10 mrad for gamma radiation and less than or equal to 20 mrad for beta radiation.
2.1.2 Dose - lodine'-131, Radioactive Material in Particulate Form with Half Lives Greater than 8 Days (Other than Noble Gases) and Tritium
- a.
The dose to an individual or dose commitment to any organ of an individual in unrestricted areas due to the release of 1-131, radioactive material in particulate form with half-lives greater than eight days (other than noble gases), and tritium in airborne effluents shall not exceed 7.5 millirem from all exposure pathways during any calendar quarter.
- b.
The dose to an individual or dose commitment to'any'organ of an individual in unrestricted areas due to the release of 1-131, radioactive materials inrparticulate form with half-lives greater than eight days (other than noble gases), and tritium in airborne effluents shall not exceed 15 millirem from all exposure pathways during any calendar year.
2.1.3 Liquid Effluents The release rate of radioactive material in liquid effluents shall be c6ntrolled such that the instantaneous concehtrations for radionuclides, other than dissolved or entrained noble gases, do not exceed the values specified in 10 CFR 20 for liquid 1-3
I effluents at site discharge. To support plant operations, Supervisor - System Chemistry may increase this limit up to the limit specified in Technical Specifications 5.16.1.b.
Technical Specification 5.16.1'.b establishes the administrative control limit on concentration of radioactive material, other than dissolved or entrained noble gases, released in liquid effluents to unrestricted areas conforming to ten times 10 CFR 20.1001-20.2401, Appendix B, Table 2, Column 2. For dissolved or entrained noble gases, the concentration shall be limited to 2.OE-04 pCi/ml total activity.
The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents released to unrestricted areas shall be limited to:
- a.
During any calendar quarter: Less than or equal to 1.5 mRem to the whole body and less than or equal to 5 mRem to any organ, and
- b.
During any calendar year: Less than or equal U
to 3 mRem to the whole body and less than or equal to 10 mRem to any organ.
2.1.4 Total Dose-Uranium Fuel Cycle The dose to any real individual from uranium fuel cycle sources shall be limited to < 25 mRem to the total body or any organ (except the thyroid, which shall be limited to < 75 mRem) during each calendar year.
2.2 Effluent Concentration Limits (ECL) 2.2.1 Liquid Effluents The values specified in 10 CFR Part 20, Appendix B, Column 2 are used as the ECL for liquid radioactive U
effluents released to unrestricted areas. A value of (9
2.OE-04 pCi/ml is used as the ECL for dissolved and entrained noble gases in liquid effluents.
Cd iJ 1-4
2.2.2 Gaseous Effluents The values specified in 10 CFR Part 20, Appendix B, Column 1 are used as the ECL for gaseous radioactive effluents released to unrestricted areas.
2.3 Measurements and ADproximations of Total Radioactivity Measurements of total radioactivity in liquid and gaseous
- radioactive effluents were accomplished in accordance with the sampling and analysis requirements of Tables 3.1 and 3.2 of Part I of the ODCM.
2.3.1 Liquid Radioactive Effluents Each batch was sampled and analyzed for gamma emitting radionuclides using gamma spectroscopy, prior to release. Composite samples were analyzed monthly and quarterly for the Monitor and Hotel Waste Tanks. Composite samples were analyzed monthly in the onsite laboratory for tritium and gross alpha radioactivity using liquid scintillation and proportional counting techniques respectively.
Composite samples were analyzed quarterly for Sr-89, Sr-90 and Fe-55 by a contract laboratory (Teledyne Brown Engineering). A software program was used to project the total body and critical organ dose contribution at the unrestricted area boundary for each release and the percent contribution to the annual objective dose.
For continuous releases from the Steam Generator blowdown, daily grab samples were obtained for weekly, monthly and quarterly composites, in proportion to the rate of blowdown. Samples were analyzed using gamma spectroscopy techniques weekly.- Composites were also analyzed monthly in the onsite laboratory for tritium and gross alpha radioactivity using liquid scintillation and proportional counting techniques, respectively. Composite samples were analyzed quarterly for Sr-89, Sr-90, and Fe-55 by a contract laboratory (Teledyne Brown Engineering).
1-5
2.3.2 Gaseous Radioactive Effluents Each gaseous batch release was sampled and analyzed for radioactivity prior to release. For release of Waste Gas Decay Tanks, noble gas grab samples were analyzed for gamma emitting radionuclides using gamma spectroscopy. For releases from the Containment Building, samples were taken using charcoal and particulate filters, in addition to noble gas and tritium grab samples, and analyzed for gamma emitting radionuclides prior to each release.
The results of the analysis and the total volume of effluent released were used to determine the total amount of radioactivity released in the batch mode. A software program was developed and installed that can project the total body and critical organ dose contribution at the unrestricted area boundary for each release and the percent contribution to the annual objective dose. This program also adds the projected dose to the current actual dose totals in a temporary file, until it is updated with actual release data at the completion of a purge.
Continuous release effluent pathways were continuously sampled using charcoal and particulate IJ filters and analyzed weekly for gamma emitting radionuclides using gamma spectroscopy. Weekly particulate filters were analyzed for gross alpha radioactivity in the onsite laboratory using proportional counting techniques. Quarterly composites of particulate filters were analyzed for Sr-89 and Sr-90 by an offsite laboratory (Teledyne Brown Engineering).
2.4 Estimation of Total Percent Error The estimated total percent error is calculated as follows:
Total Percent Error = (El2 + E22 + E32 +... + En Where En = Percent Error Associated with each contributing parameter.
Sample counting error is estimated by the Canberra Genie System Software for samples analyzed by gamma spectroscopy. This calculation can include the error 1-6
associated with peak area determination, gamma ray abundance, efficiency-and half-life. Systematic error is estimated for gaseous and liquid effluent analyses and dilution and wastewater volume.
2.5 Batch Releases A summary of information for liquid and gaseous batch releases is included in Table 111-1.
2.6 Abnormal Releases Abnormal Releases are defined as unplanned and unmonitored releases of radioactive material from the site.
A summary of information for liquid and gaseous abnormal releases is included in Table 111-2.
3.0 GASEOUS EFFLUENTS The quantities of radioactive material released in gaseous effluents are summarized in Tables 111-3,111-4 and 111-5. All radioactive material released in gaseous form is considered to be ground level releases.
4.0 LIQUID EFFLUENTS The quantities of radioactive material released in liquid effluents are summarized in Tables 111-6, 111-7 and 111-8.
5.0 SOLID WASTES The quantities of radioactive material released as solid effluents are summarized in Section VI.
6.0 RELATED INFORMATION 6.1 Operabilitv of Liquid and Gaseous Monitoring Instrumentation During the reporting period no instruments used to monitor radioactive effluent releases were in violation of the reportable instrument operability requirements listed in the ODCM.
1-7
6.2 Changes to the Offsite Dose Calculation Manual (ODCM) or Process Control Program (PCP)
During 2003 there was one change made to the ODCM and no changes made to the PCP.
6.3 New Locations or Modifications for Dose Calculations or Environmental Monitoring No new receptor locations were identified which resulted in changes to our environmental monitoring sample locations.
6.4 Noncompliance with Radiological Effluent Control Requirements This section provides a list of any event that did not comply K
with the applicable requirements of the Radiological Effluent Controls given in the Offsite Dose Calculation Manual (ODCM). Detailed documentation concerning the evaluations and corrective actions is maintained onsite.
6.4.1 Abnormal Gaseous and Liquid Releases No abnormal releases were made during the calendar year of 2003.
6.4.2 Failure to Meet Specified Sampling Requirements During 2003 there were no instances in which K
specified sampling requirements were not met.
6.5 Modifications to Liquid and Gaseous Waste Treatment and Ventilation Exhaust Systems During the reporting period no design modifications were approved nor implemented involving major changes to the Liquid and Gaseous Waste Treatment Systems.
6.6 Meteorological Monitoring Program A summary of hourly meteorological data, collected during 2003, is retained onsite. This data is available for review by the Nuclear Regulatory Commission upon request. Joint Frequency tables are included in Section VII, Attachment 2.
1-8
Real time hourly meteorological data is used to calculate the annual air effluent dose to individuals. For quarterly estimates during the year an annual average X/Q is used which is an average of the highest XIQs calculated for each of the previous two years.
6.7 Assessment of Doses 6.7.1 Doses Due to Liquid Effluents Total body, skin, and organ dose for liquid releases were calculated in mRem for all significant liquid pathways using the annual configuration of the LADTAP II program. The site discharge location was chosen to present a most conservative estimate of dose for an average adult, teenager, child and infant.
A conservative approach is also presented by the assumption that Omaha and Council Bluffs receive all drinking water from the Missouri River.
The LADTAP II program in its annual configuration was also used to calculate the total body and organ doses for the population of 853,274 within a 50-mile radius of the plant (based on the 2000 census). The results of the calculations are listed in Section V.
The dose due to liquid effluents for total body and critical organ are' also calculated 'quarterly using the methods in the ODCM. The results are listed in Section II.
6.7.2 Doses Due to Gaseous Effluents Total body, "skin and organ doses from ground releases were calculated in mRem to an average adult, teenager, child, and infant in each receptor using the annual configuration of the GASPAR II program. Also, the doses to the same groups, in units of mrad, due to gamma and beta radiation carried by air, were computed using GASPAR II.
The GASPAR II program in its annual configuration was also used to calculate the ALARA integrated population dose summary for the total body, skin and organ doses in person-rem for all individuals within a 50-mile radius. The results of the calculations are shown in Section IV.
.1-9
The dose due to gaseous effluents for total body gamma and beta noble gas air dose are calculated quarterly using the methods in the ODCM with an annual average X/Q. The results are listed in Section II.
6.7.3 Doses Due to 1-131. Tritium and Particulates with Half Lives Greater than 8 days.
The doses due to 1-131, Tritium and Particulates with half lives greater than 8 days for total body and critical organ dose are calculated quarterly using the highest of infant or child dose factors and an annual average X/Q. The results are listed in Section II for inhalation, ground and food.
6.7.4 Direct Radiation Dose to Individuals and Populations Direct radiation doses attributed to the gamma radiation emitted from the containment structure were not observed above local background at any TLD u
sample locations for this annual period.
6.7.5 40 CFR 190 Dose Evaluation ODCM Radiological Effluent Controls require dose evaluations to demonstrate compliance with 40 CFR Part 190 only if calculated yearly doses exceed two times the annual design objectives for liquid and/or gaseous effluents. At no time during 2003 were any of these limits exceeded, therefore, no evaluations were required.
1-10
SECTION II QUARTERLY DOSES FROM EFFLUENTS Offsite Dose Calculation Manual January 1, 2003 - December 31, 2003 11-1
Quarterly Dose Calculation Results January 1, 2003 through December 31, 2003 With the implementation of the Fort Calhoun Station Radiological Effluent Technical Specifications (RETS) on October 1, 1985, radiation doses in the unrestricted area from liquid and gaseous effluents must be calculated on a quarterly basis in accordance with the Offsite Dose Calculation Manual (ODCM). These calculations are performed to ensure the annual dose limits delineated in Appendix I of 10 CFR 50 and implemented by RETS are not exceeded. If the results of the quarterly calculations exceed fifty percent (50%) of the annual limits of Appendix 1, actions are taken to reduce effluents so that the resultant doses do not exceed the annual limits during the remainder of the year and a special report is submitted to the Nuclear Regulatory Commission.
This section presents the results of the quarterly dose calculations.
performed during the period January 1, 2003 through December 31, 2003.
Details are shown as to the types, sources and resultant doses from the effluents, the annual limits and a comparison to the annual limits.
11-2
FORT CALHOUN STATION CHEMISTRY FORM FC-421 R6 QUARTERLY CUMULATIVE DOSE CONTRIBUTION FROM RADIOACTIVE EFFLUENTS FORT CALHOUN FIRST QUARTER 2003 DOSE PROJECTIONS I. Liquid Effluents:
Batch:
Continuous:
Totals:
ODCM Quarterly Objective:
Percent of Quarterly Obj:
ODCM Annual Objective:
YTDPercentof___nual_____
YTD Percent of Annual Obj:
Total Body Dose (mrem) 3.64E-02 0.OOE+00 3.64E-02 1.50E+00 2.43 %
3.OOE+00 1.21 %
Critical Organ Dose (mrem).
4.87E-02 0 OOE+00 4.87E-02 5.OOE+00 0.97 %
1.OOE+01 0.49 %
1-.
II. Gaseous Effluents:
Total Body Gamma Dose (mrad)
A. Noble Gas Air Dose:
1.18E-03 ODCM Quarterly Objective:
5.OOE+00 Percent of Quarterly Obj:
0.02 %
ODCM Annual Objective:
1.OOE+01 YTD_ ercetofAnnal_____001_
YTD Percent of Annual Obj:
0.01%
Total Body Beta Dose (mrad) 1.56E-03 1.OOE+01 0.02 %
2.OOE+01 0.01 %
'-/
B. I-131, H-3, and Particulates with Half-lives > 8 Days:
Inhalation:
Ground and Food:
Totals:
ODCM Quarterly Objective:
Percent of Quarterly Obj:
ODCM Annual Objective:
YTDPercentofAnnual_____
YTD Percent of Annual Obj:
Total Body Dose (mrem) 5.83E-06 2.90E-05 3.48E-05 7.50E+00 0.00 %
1.50E+01 0.00 %
Critical Organ Dose (mrem) 1.81E-04 2.06E-03 2.24E-03 7.50E+00 0.03 %
1.50E+01 0.01 %
'-I 11-3
FORT CALHOUN STATION CHEMISTRY FORM FC-421 R6 QUARTERLY CUMULATIVE DOSE CONTRIBUTION FROM RADIOACTIVE EFFLUENTS FORT CALHOUN SECOND QUARTER 2003 DOSE PROJECTIONS I. Liquid Effluents:
Batch:
Continuous:
Totals:
ODCM Quarterly Objective:
Percent of Quarterly Obj:
ODCM Annual Objective:
YTDPercentofAnnual_____
YTD Percent of Annual Obj:
Total Body Dose (mrem) 1.66E-02 0.OOE+00 1.66E-02 1.50E+00 1.11 %
3.OOE+00 1.77 %
Critical Organ Dose (mrem) 2.15E-02 0.OOE+00 2.15E-02 5.OOE+00 0.43 %
1.OOE+01 0.69 %
Tota Bod Bet II.- Gaseous Effluents:
Total Body Gamma Dose (mrad)
A. Noble Gas Air Dose:
1.38E-03 ODCM Quarterly Objective:
5.OOE+00 Percent of Quarterly Obj:
0.03 %
ODCM Annual Objective:
1.OOE+01
__ YTDercetofAnnal____00 YTD Percent of Annual Obj:-
0.03%
Total--Body Beta Dose (mrad) 1.55E-03 1.OOE+01 0.02 %
2.OOE+01 0.02 %
B. I-131, H-3, and Particulates with Half-lives > 8 Days:
Inhalation:
Ground and Food:
Totals:
ODCM Quarterly Objective:
Percent of Quarterly Obj:
ODCM Annual Objective:
YTD__PercentofAnnual___._
YTD Percent of Annual Obj:
Total Body Dose (mrem) 1.55E-05 1.29E-04 1.44E-04 7.50E+00 0.00 %
1.50E+01
-Critical Organ Dose (mrem) 3.51E-04 4.82E-03 5.17E-03 7.50E+00 0.07 %
1.50E+01 0.00 %
0.05 %
11-4
FORT CALHOUN STATION CHEMISTRY FORM FC-421 RG QUARTERLY CUMULATIVE DOSE CONTRIBUTION FROM RADIOACTIVE EFFLUENTS FORT CALHOUN THIRD QUARTER 2003 DOSE PROJECTIONS I. Liquid Effluents:
Batch:
Continuous:
Totals:
ODCM Quarterly Objective:
Percent of Quarterly Obj:
ODCM Annual Objective:
YTD Percent of Annual Obj:
Total Body Dose (mrem) 5.20E-02 9.22E-06 5.20E-02 1.50E+00 3.47 %
- 3. OE+00 3.50 %
Critical Organ Dose (mrem) 6.89E-02 1.47E-05 6.89E-02 5.OOE+00 1.38 %
1.OOE+01 1.38 %
tal Body Gamma II. Gaseous Effluents:
To A. Noble Gas Air Dose:
ODCM Quarterly Objective:
Percent of Quarterly Obj:
ODCM Annual Objective:
YTD Percent of Annual Obj:
ztal Body Gamma Dose (mrad) 2.55E-03 5.OOE+00 0.05 %
1.OOE+01 0.05 %
Total Body Beta Dose (mrad) 4.69E-03 1.OOE+01 0.05 %
2.OOE+01 0.04 %
'-I I -/
B. I-131, H-3, and Particulates with Half-lives > 8 Days:
Inhalation:
Ground and Food:
Totals:
ODCM Quarterly Objective:
Percent of Quarterly Obj:
ODCM Annual Objective:
YTDPercentofAnnual__b__
YTD Percent of Annual Obj:
Total Body Dose (mrem) 1.16E-03 5.36E-03 6.52E-03 7.50E+00 0.09 %
1.50E+01 0.04 %
Critical Organ Dose (mrem) 2.46E-03 2.35E-02 2.60E-02 7.50E+00 0.35 %
1.50E+01 0.22 %
11-5
FORT CALHOUN STATION CHEMISTRY FORM FC-421 R6 QUARTERLY CUMULATIVE DOSE CONTRIBUTION FROM RADIOACTIVE EFFLUENTS FORT CALHOUN FOURTH QUARTER 2003 DOSE PROJECTIONS I. Liquid Effluents:
Batch:
Continuous:
Totals:
ODCM Quarterly Objective:
Percent of Quarterly Obj:
ODCM Annual Objective:
Total Body Dose (mrem) 8.25E-03 4.09E-05 8.29E-03 1.50E+00 0.55 %
3.OOE+00 Critical Organ Dose (mremi).
1.08E-02 6.39E-05 1.09E-02 5.00E+00 0.22 %
1.OOE+01 YTDPercentof___nual_____
YTD Percent of Annual Obj:
3.77 %
1.49 %
II. Gaseous Effluents:
Total Body Gamma II. Gaseous Effluents:
Total Body Gamma Dose (mrad)
A. Noble Gas Air Dose:
8.73E-04 ODCM Quarterly Objective:
5.OOE+00 Percent of Quarterly Obj:
0.02 %
ODCM Annual Objective:
1.00E+01 YTD Percent of Annual Obj:
0.06 %
Total Body Beta Dose (mrad) 9.03E-04 1.00E+01 0.01 %
2.OOE+01 0.04 %
B. I-131, H-3, and Particulates with Half-lives > 8 Days:
Inhalation:
Ground and Food:
Total Body Dose (mrem) 2.19E-05 1.04E-04 1.26E-04 Critical Organ Dose (mrem) 1.69E-04 2.89E-03 3 _ _ -
0__
3.06E-03 Totals:
ODCM Quarterly Objective:
Percent of Quarterly Obj:
ODCM Annual Objective:
YTDPercentofAnnual_____
YTD Percent of Annual Obj:
- 7. 50E+00 0.00 %
- 1. 50E+01 0.05 %
7.50E+00 0.04 %
- 1. 50E+01 0.24 %
11-6
SECTION III RADIOLOGICAL EFFLUENT RELEASES Technical Specification (5.9.4.a)
Table 111-1 Table 111-2 Table 111-3 Table 111-4 Table 111-5 Table 111-6 Table 111-7 Table 111-8 Batch Liquid and Gas Release Summary Abnormal Batch Liquid and Gaseous Release Summary Gaseous Effluents - Summation of all Releases Gaseous Effluent Releases - Batch Mode Gaseous Effluent Releases - Continuous Mode Liquid Effluents - Summation of all Releases Liquid Effluent Releases - Batch Mode Liquid Effluent Releases - Continuous Mode January 1, 2003 - December 31, 2003 111-1
C C ( C C C (
C C ( C ( ( ( ( ( ( ( ( ( ( ( ( ( C ( C C C C C
(
C C C C C C C C C C C TABLE III.1 BATCH LIQUID AND GASEOUS RELEASE
SUMMARY
JANUARY THROUGH DECEMBER 2003 A. Liquid Releases All Sources 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter 1.
2.
3.
4.
5.
6.
Number of Batch Releases:
Total Time-Period for Batch Releases(min):
Maximum Time Period for Batch Releases(min):
Average Time Period for Batch Releases(min):
Minimum Time Period for Batch Releases(min):
Average Dilution Stream Flow During Periods of Release into the Missouri River(mls/min):
26 3,100 160 119 99 1.223E+09 24 2,936 167 122 102 1.363E+09 60 20, 362 8,251 339 88
- 7. 975E+08 50 8,306 418 166 55
- 7. 842E+08 B. Gaseous Releases All Sources 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter 1.
2.
3.
4.
5.
Number of Batch Releases:
Total Time Period for Batch Releases(min):
Maximum Time Period for Batch Releases(min):
Average Time Period for Batch Releases(min):
Minimum Time Period for Batch Releases(min):
18 65,497 5,047 3, 639 327 18 66, 999 5,410 3,722 285 46 116, 609 23,094 2,535
.100 20 78, 272 8,085 3,914 321 III-2
TABLE III.2 ABNORMAL BATCH LIQUID AND GASEOUS RELEASE
SUMMARY
JANUARY THROUGH DECEMBER 2003 A. Liquid Releases All Sources Number of Releases:
Total Activity Releases(Ci):
B. Gaseous Releases All Sources Number of Releases:
Total Activity Releases (Ci):
1st Quarter 2nd Quarter 3rd Quarter 4th Quarter 0
0 0
0 0.OOE+00 0.OOE+00 0
0.OOE+00 0.OOE+00 0
0.OOE+00 0.OOE+00 0
0.0OOE+O0 0
0.OOE+00 III-3 C C (
C (
(-
(
( C (- (C (C
C(
(.- (
( (C
(
(
(
(
(, (
(
(
(
(
(
(
(
(
(
(
(
(
(
(
TABLE III.3 GASEOUS EFFLUENTS--SUMMATION OF ALL RELEASES JANUARY THROUGH DECEMBER 2003 A. Fission & Activation Gases Total Release (Ci):
Avg. Release Rate for period (uCi/sec):
Total Error(%): 37.97 1st Quarter 3.22E+00 4.18E-01 2nd Quarter 3.13E+00 4.02E-01 3rd Quarter 1.1lE+01 1.41E+00 4th.Quarter 1.75E+00 2.23E-01 B. Iodines Total Release (Ci):
Avg. Release Rate for period (uCi/sec):
Total Error(%): 54.07 8.27E-05
.1.
08E-05 1.41E-04 1.81E-05
- 5. 67E-03 7.21E-04 1.77E-04 2.26E-05 C. Particulates Total Release (Ci):
Avg. Release Rate for period (uCi/sec):
Total Error(%): 57.73 Gross Alpha Total Error(%): 20.62
- Alpha activity attributed D. Tritium Total Release (Ci):
Avg.
Release Rate for period (uCi/sec):
Total Error(%) : 25.08 0.OOE+00 0.00E+00
- 5. 64E-06*
5.32E-06 6.84E-07
- 4. 96E-06
- 0. OOE+00
- 0. OOE+00 9.55E-06*
- 0. OOE+00
- 0. OOE+00 8.20E-06
- to naturally occuring short lived alpha emitters.
2.12E-02 2.75E-03 5.42E-02 6.98E-03 4.39E+00 5.59E-01 8.22E-02
- l.
05E-02 NOTE:
Values reported as zero are determined to be below the Lower Limit of Detection (LLD).
III-4
TABLE III.4 GASEOUS EFFLUENTS--GROUND LEVEL RELEASES JANUARY THROUGH DECEMBER 2003 Batch Mode Nuclides(Ci) 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter Fission & Activation Gases AR-41 KR-85 KR-85M KR-87 KR-88 XE-131M XE-133 XE-133M XE-135 Totals for Period:
Iodines Totals for Period:
2.39E-01 3.31E-01 2.4 6E-03 0.OOE+00 6.57E-04
- 7. 25E-03 2.29E+00
- 2. 81E-02 6.83E-02 2.97E+00
- 0. OOE+00 2.85E-01 1.70E-01 2.67E-03 0.OOE+00 2.59E-04 0.OOE+00 2.31E+00 3.32E-02 7.89E-02 2.60E-01
- 1. 56E-02 5.03E-02
- 8. 32E+00
- 8. 77E-02
- 2. 97E-01
- 1. 64E-01 3.93E-02 4.73E-03 1.86E-03 6.21E-03,
5.17E-03 t 1.36E+00 2.OOE-02,
1.1OE-01 1.71E+00 '
- 0. OOE+00,
2.88E+00 9.15E+00 0.OOE+00 0.00E+00 Pariculates Totals for Period:
0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Tritium and Gross Alpha H-3
- 2. 12E-02 5.42E-02
- 4. 39E+00 8.22E NOTE: Values reported as zero are determined Detection (LLD).
to be below the Lower Limit of I-,
III-5 I
iI_
TABLE III.5 GASEOUS EFFLUENTS--GROUND LEVEL RELEASES JANUARY THROUGH DECEMBER 2003 Continuous Mode 1st Quarter 2nd Quarter Nuclides(Ci)
Fission & Activation Gases 3rd Quarter 4th Quarter XE-133 XE-135 Totals for Period:
Iodines I-131 I-132 I-133 Totals for Period:
2.45E-01 0.OOE+00 2.45E-01 1.36E-05 0.OOE+00
- 6. 92E-05 8.27E-05 1.86E-01 6.71E-02 2.53E-01 3.20E-05
- 0. OE+00 1.09E-04 1.41E-04
- 1. 85E+00 9.57E-02
- 1. 95E+00 1.35E-04 5.33E-03 2.01E-04
- 0. OOE+00
- 0. OOE+O0 1.85E-06 3.47E-06 0
.OOE+O0
- 0. OOE+00
- 0. OOE+00 0.OOE+00
- 0. OOE+00 0.OOE+00 Totals for Period:
0.OOE+00 5.32E-06 Tritium and Gross Alpha ALPHA 5.64E-06
- 4. 96E-06 9.55E-06 8.20E-06 NOTE:
Values reported as Detection (LLD).
zero are determined to be below the Lower Limit of III-6
TABLE III.6 LIQUID EFFLUENTS--SUMMATION OF ALL RELEASES JANUARY THROUGH DECEMBER 2003 1st Quarter A.
Fission & Activation Products Total Release (No Tritium, Gas, Alpha) (Ci):
Avg Diluted Concentration (uCi/ml):
10 CFR 20, App. B Limit 1.OOE-06 uCi/ml Percent of Limit (%):
Total Error (%):
29.38 B. Tritium Total Release (Ci):
Avg Diluted Concentration (uCi/ml):
10 CFR 20, App. B Limit 1.OOE-03 uCi/ml Percent of Limit (%):
Total Error (%):
25.08 C. Dissolved & Entrained Gases Total Release (Ci):
Avg Diluted Concentration (uCi/ml):
ODCM Limit 2.OOE-04 uCi/ml Percent of Limit (%):
Total Error (%):
30.66 D. Gross Alpha Radioactivity Total Release (Ci):
Total Error (%):
25.08 E. Volume of Waste Released Prior to Dilution (Liters):
2.61E-02
- 8. 12E-11 8.12E-03 6.15E+01
- 1. 91E-07 1.91E-02
- 9. 66E-04 3.OOE-12 1.50E-06
- 9. 17E-05 5.4 6E+07 2nd Quarter 1.54E-02 4.40E-ll 4.40E-03 8.70E+01 2.49E-07 2.4 9E-02 5.94E-04 1.70E-12 8.50E-07 4.36E-04 4.45E+07 3rd Quarter 2.41E-02 8.15E-ll 8.15E-03 1.20E+02 4.06E-07 4.06E-02 3.20E-03 1.08E-11 5.40E-06 1.1lE-03 3.44E+07 4th-.Quarter 4.08E-02 2.19E-10 2.19E-02 2.61E+01
- 1. 40E-07
- 1. 40E-02 7.OOE-04 3.76E-12 1.88E-06 3.40E-03 3.16E+07 F. Volume of Dilution Water This Period (Liters):
3.22E+11
- 3. 49E1 1
- 2. 96E+11
- 1. 86E+ll
`
I/
I NOTE:
Values reported as zero are determined to be below the Lower Limit of Detection (LLD).
III-7
TABLE III.7 LIQUID EFFLUENTS JANUARY THROUGH DECEMBER 2003 Batch Mode Nuclides(Ci)
Fission & Activation Gases AG-l1OM BA-140 BE-7 CE-144
'CO-57 CO-58 CO-60 CR-51 CS-134 CS-137 FE-55 FE-59 HF-181 I-131 I-132 I-133 LA-140 MN-54 NB-95 PR-144 RU-103 SB-122 SB-124 SB-125 SB-126 SE-75 SN-113 SN-117M SR-89 SR-90 TE-129 TE-129M TE-132 Y-90 ZN-65 ZR-95 Totals for Period:
1st Quarter 2nd Quarter 3rd Quarter 4th Quarter 2.88E-03
- 0.
OOE+00
- 0.
OOE+00
- 5. 69E-05
- 9. 64E-05 5.28E-03
- 4. lOE-03 0.OOE+00 1.8 6E-03 3.25E-03
- l. 42E-03 0.OOE+00 0.OOE+00 7.39E-04 0.OOE+00 1.81E-05 5.23E-05 3.12E-04 1.04E-03
- 5. 69E-05 0.OOE+00
- 0. OOE+00 3.71E-06
- 4. 69E-03 0.OOE+00 3.31E-06 0.OOE+00 0.OOE+00 3.67E-05 1.47E-05 0.OOE+00 0.OOE+00 0.OOE+00 1.47E-05 0.OOE+00 2.23E-04 2.61E-02 2.19E-03 2.34E-03 1.61E-03 0.OOE+00 9.87E-05 0.OOE+00 O.OOE+DO 0.OOE+00 --
6.61E-05 3.98E-05 0.OOE+00 1.66E-05 5.54E-06 5.93E-05 3.55E-05 3.37E-04 1.60E-03 5.34E-D3 7.41E-04 1.25E-03 8.18E-04 3.85E-04 1.03E-03 2.03E-03 5.75E-04 2.32E-03 3.26E-04 1.07E-03 4.76E-03 6.72E-04 0.OOE+00 0.OOE+00 2.29E-03 0.OOE+00 1.15E-04
- 7.73E-05 0.OOE+00 0.OOE+00 3.69E-06 0.OOE+00 1.08E-04 4.09E-04 0.OOE+00 1.35E-03 5.68E-05 0.OOE+00 0.OOE+00 0.OOE+00 9.36E-06 9.69E-04 2.75E-04 5.40E-05 8.15E-05 9.55E-05 2.56E-05 3.24E-04 6.98E-04 3.98E-05 0.OOE+00 1.66E-05 7.16E-07 4.24E-05 9.95E-05 0.OOE+00 1.77E-05 0.OOE+00 1.57E-05 8.15E-05 2.74E-03 9.81E-03 6.87E-03 1.88E-02 0.OOE+00 0.OOE+00 8.50E-05 4.49E-05 2.68E-04 2.82E-04 0.OOE400 6.12E-06 1.OOE-05 0.OOE+00 5.17E-06 8.33E-06 0.OOE+00 0.OOE+00 6.82E-05 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 9.85E-06 9.13E-05 0.OOE+00 0.OOE+00 3.31E-03 1.68E-06 2.87E-04 1.88E-05 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 1.39E-05 1.21E-04 1.74E-05 1.15E-04 2.62E-04 1.54E-02 2.41E-02 4.08E-02 Dissolved & Entrained Gases AR-41 KR-88 XE-131M XE-133 XE-135 Totals for Period:
O.OOE+C0 8.74E-06 0.OOE+00 9.57E-04 0.OOE+00 9.66E-04 0.OOE+00 8.69E-06 O.OOE+00 0.OOE+00 0.OOE+00 1.56E-04 5.92E-04 3.02E-03 1.60E-06 7.92E-06 5.94E-04 3.20E-03 0.OOE+O0 O.OOE+00 0.OOE+00 7.OOE-04 0.OOE+00 7.OOE-04 Tritium and Gross Alpha ALPHA H-3 9.17E-05 6.15E+01 4.36E-04 8.70E+Ol
- 1. 11E-03 1.20E+02 1.87E-03 2.61E+01 NOTE:
Values reported as zero are determined to be below the Lower Limit of Detection (LLD) values.
III-8
TABLE III.8 LIQUID EFFLUENTS JANUARY THROUGH DECEMBER 2003 Continuous Mode Nuclides(Ci)
Fission & Activation Products CS-137 Totals for Period:
Dissolved & Entrained Gases Totals for Period:
Tritium and Gross Alpha ALPHA H-3 1st Quarter 2nd Quarter 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 3rd Quarter 1.85E-06 1.85E-06 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 N-4th Quarter 7.94E-06 7.94E-06
- 0. OOE+00 N-1.53E-03 ~
1.96E-02 Lit of NOTE:
Values reported as zero are determined to be below Detection (LLD).
the Lower Liu III-9
SECTION IV DOSE FROM GASEOUS EFFLUENTS Technical Specification 5.9.4.a GASPAR II OUTPUT January 1, 2003 - December 31,2003 IV-1
Radioactive Effluent Releases - First, Second, Third and Fourth Quarters 2003 GASEOUS EFFLUENTS Radioactive gaseous releases for the reporting period totaled 1.92E+01 Curies of inriet gas. The gross gaseous activity release rates were 4.18E-01 pCi/sec for the first quarter, 4.02E-01. pCi/sec for the second quarter, 1.41 E+00 pCi/sec for the third quarter, and 2.23E-01 pCi/sec for the fourth quarter.
Radioactive halogens and Particulates with half-lives greater that eight days released during the reporting period totaled 6.07E-03 Curies. The halogen release rates were 1.08E-05 pCi/sec for the first quarter, 1.81 E-05 pCi/sec for the second quarter, 7.21 E-04 pCisec for the third quarter, and 2.26E-05 pCi/sec for the fourth quarter. The release rates for Particulates with half-lives greater than eight days were 0.OOE+00 pCi/sec for the first quarter, 6.84E-07 pCi/sec for the second quarter, 0.00E+00 pCi/sec for the third quarter and 0.OOE+00 pCi/sec for the fourth quarter.
Radioactive tritium released during the reporting period totaled 4.55E+00 Curies. Gross alpha radioactivity released during the reporting period totaled 2.84E-05 Curies.
Reanalysis of alpha samples indicated that the reported concentration was attributed to short lived, natural occurring, alpha emitters.:
IV-2
POTENTIAL DOSES TO INDIVIDUALS AND POPULATIONS A.
Potential Annual Doses to Individuals from Gaseous Releases Total body, skin, and organ doses from ground releases were calculated in mRem to an average adult, teenager, child, and infant using the annual configuration of the GASPAR II program. Results to each receptor are shown in Tables IV-A-1 through IV-A-39. Also, the doses to the same groups, Table IV-B-1, in units of mrad, due to gamma and beta radiation carried by air, were computed using GASPAR II. In its annual configuration, GASPAR II assumes that all release rates are entered in curies per year (Cilyr).
The inputs to GASPAR II for the annual period from January 1,2003 through December 31, 2003 were as follows:
(1)
All gaseous effluents (2)
Entrained gases (Ar-41, Xe-131M, Xe-133M, Xe-133, Xe-135M, Xe-135, Kr-85M, Kr-87, and Kr-88) from liquid effluents.
(3)
Annual X/Qs at the actual receptor locations, which are corrected for open terrain and plume depletion, are calculated according to Regulatory Guideline 1.111. Also included are annual deposition rates corrected for the open terrain factor.
(4)
The production, intake and grazing fractions were as follows: 1.0 for leafy vegetables grown in garden of interest, 0.76 for produce grown in garden of interest, 0.5 for the pasture grazing season of the milk animal, 1.0 for pasture grazing season of the meat animal, and 8 g/m3 for the air water (humidity) concentrations.
(5)
All dose factors, transport times from receptor to individual, and usage factors are defined by Regulatory Guide 1.109 and NUREG-0172.
(6)
Site specific information, within a five-mile radius of the plant, on types of receptors located in each sector was used. That is, if a cow was not present in a sector, then the milk pathway for that sector was not considered. If it was present, then the actual sector distance was used.
IV-3
These inputs introduce a most conservative approach for the following reasons:
(1)
The open terrain and deposition corrections increase annual X/Qs by a factor ranging between 1.0 and 4.0 (2)
The production, intake, and grazing fractions, as defined in the input definition statement, represent the environment in an extremely conservative manner.
B.
Potential Semiannual Doses to Population from Gaseous Releases The GASPAR II program in its annual configuration was also used to calculate the ALARA integrated population dose summary for the total body, skin, and organ doses in man-rem for all individuals within a 50-mile radius. The population-integrated dose is the summation of the dose received by all individuals and has units of man-thyroid-rem when applied to the summation of thyroid doses. The same inputs were used as in the individual case with the addition of the following:
(1)
A total population of 853,274 (based on the 2000 census) was used to define the sector segments within a 50-mile radius of the plant.
(2)
Production of milk, meat,and vegetation is based on 1973 annual data for Nebraska as recommended by the Nuclear Regulatory Commission for use in GASPAR II.
IV-4
TABLE IV-A-1 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
1 RES AT 4.57 MILES N ANNUALBETAAIRDOSE = 6.56E-05 MILLRADS ANNUALGAMMAAIRDOSE = 2.83E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
___-_+- _________ +_________-+__________+__________+__________+__________+_____---____-+__-
+
PLUME
- 1.73E-05 : 1.73E-05 : 1.73E-05 : 1.73E-05 : 1.73E-05 : 1.73E-05 : 1.80E-05 : 4.63E-05
_________+-______-__+______-___+________-_+________-_+________-_+________-_+__________+_____-__-_+
GROUND
- 8.13E-07 : 8.13E-07 : 8.13E-07 : 8.13E-07 : 8.13E-07 : 8.13E-07 : 8.13E-07 : 9.50E-07
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INHAL ADULT 1.04E-05 1.04E-05 3.30E-08 1.04E-05 1.04E-05 1.95E-05 1.04E-05 1.04E-05
__+______-___+_________-+________-_+________-_+________-_+________-_+________-_+________-_+
TEEN
- 1.05E-05 : 1.05E-05 : 4.61E-08 : 1.05E-05 : 1.06E-05 : 2.20E-05 : 1.05E-05 : 1.05E-05
_________+-_________+________-_+_________-+________-_+________-_+_______-__+________-_+________-_+
CHILD
- 9.27E-06 : 9.25E-06 : 6.23E-08 : 9.31E-06 : 9.34E-06 : 2.27E-05 : 9.23E-06 : 9.23E-06
_________+-_________+_______-__+________-_+________-_+________-_+________-_+________-_+________-_+
INFANT : 5.33E-06 : 5.32E-06 : 4.75E-08 : 5.38E-06 : 5.38E-06 : 1.76E-05 : 5.31E-06 : 5.31E-06
_________+______-___+__________+__________+__________+_______-__+__________+__________+______V___+
IV-5
C C C (I (C
C C C C C C C(
( ( ( (C C
C(
( C C C C ( ( ( ( (C( C C C c ( C TABLE IV-A-2 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
2 RES AT 1.93 MILES NNE ANNUAL BETA AIRDOSE = 3.13E-04 MILLRADS ANNUAL7GAMMAAIRDOSE = 2.15E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+ __
_ ___--+__________+ __________+__________+__________+__________+______--____+____--_
+
PLUME
- 1.37E-04 : 1.37E-04 : 1.37E-04 : 1.37E-04 : 1.37E-04 : 1.37E-04 : 1.40E-04 : 3.OOE-04
-________+______-___+_________-+_________-+__________+-_________+__________+_________-+________-_+
GROUND
- 4.43E-06 4.43E-06 : 4.43E-06 : 4.43E-06 : 4.43E-06 : 4.43E-06 : 4.43E-06 : 5.18E-06
-________+____-__
__+_________-+________-_+________-_+________-_+________-_+________-_+________-_+
INHAL ADULT 4.27E-05 4.26E-05 2.02E-07 4.29E-05 4.31E-05 8.8SE-05 4.25E-05 4.25E-05
-________+______--__+-_________+_______-__+________-_+-_________+__________+-_________+_________-+
TEEN 4.31E-05 : 4.30E-05 2.80E-07 : 4.34E-05 : 4.37E-05 1.01E-04 : 4.29E-05 : 4.29E-05 CHILD
- 3.81E-05 : 3.81E-05 : 3.77E-07 3.84E-05 : 3.86E-05 : 1.07E-04 : 3.79E-05 : 3.79E-05 INFANT : 2.19E-05 : 2.19E-05 : 2.92E-07 : 2.22E-05 : 2.23E-05 : 8.49E-05 : 2.18E-05 : 2.18E-05
-________+______-___+_________-+________-_+________-_+_________-+__________+__________+_________-+
IV-6
TABLE IV-A-3 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
3 RES AT 1.52 MILES NE ANNUALBETAAIRDOSE = 4.44E-04 MILLRADS ANNUALGAMMAAIRDOSE = 2.54E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+_
________+_- -
_-------+_
+
+
+
_+__--_
+
PLUME
- 1.59E-04 : 1.59E-04 : 1.59E-04 : 1.59E-04 : 1.59E-04 : 1.59E-04 : 1.63E-04 : 3.75E-04
-________+__________+__________+__________+__________+__________+__________+___---_____+_____--_-_
GROUND
- 4.75E-06 : 4.75E-06 : 4.75E-06 : 4.75E-06 : 4.75E-06 : 4.75E-06 : 4.75E-06 : 5.55E-06
-________+__________+----______+__________+__________+__________+__________+___--_____+__________+
INHAL ADULT 6.45E-05 6.44E-05 2.71E-07 6.48E-05 6.50E-05 1.30E-04 6.43E-05 6.42E-05
+-
+-------------------+-
+
+
+--
TEEN
- 6.51E-05 : 6.50E-05 : 3.77E-07 : 6.55E-05 : 6.59E-05 : 1.49E-04 : 6.48E-05 : 6.48E-05
+-
+------------------
+
+
+--
CHILD
- 5.75E-05 : 5.75E-05 : 5.08E-07 : 5.79E-05 : 5.82E-05 : 1.56E-04 : 5.73E-05 : 5.72E-05
-+------------+-
+-------------------+-
+
+
+--
INFANT : 3.31E-05 : 3.31E-05 : 3.90E-07 : 3.35E-05 : 3.36E-05 : 1.23E-04 : 3.29E-05 : 3.29E-05
+-
+-------------------+-
+
+
+--
IV-7 C C (
C (
(.
(
(.
(
(
C (
(
C (
(
C C (
(
(
C C (
l
(
(
(
(
(
(
(
C
(
(
(
C
(
(
C CCC c
C C((C
( ( ( (
(
(
c c ( (
(
( ( ( ( (CCC ( (
TABLE IV-A-4 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
4 RES AT 4.79 MILES ENE ANNUALBETAAIRDOSE = 3.58E-05 MILLRADS ANNUALGAMMAAIRDOSE = 1.50E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+__ _ ___--+_________-+__________+__________+__________+__________+______--____+____--_
_ +
PLUME
- 9.17E-06 : 9.17E-06 : 9.17E-06 : 9.17E-06 : 9.17E-06 : 9.17E-06 : 9.52E-06 : 2.48E-05
-________+______-___+_________-+-_________+_________-+________-_+________-_+________-_+________-_+
GROUND 2.12E-07 : 2.12E-07 : 2.12E-07 : 2.12E-07 : 2.12E-07 : 2.12E-07 :-2.12E-07 : 2.48E-07
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INHAL ADULT 5.71E-06 5.71E-06 1.79E-08 5.73E-06 5.74E-06 1.07E-05 5.70E-06 5.70E-06
_________+__________+__________+__________+__________+__________+__________+__________+__________+
TEEN 5.77E-06 5.i6E-06 : 2.SOE-08 : 5.79E-06 : 5.81E-06 : 1.20E-05 : 5.75E-06 : 5.75E-06 CHILD
- 5.10E-06 : 5.09E-06 : 3.37E-08 : 5.12E-06 : 5.14E-06 : 1.24E-05 : 5.08E-06 : 5.08E-06
-________+______-___+__________+_________-+________-_+________-_+________-_+________-_+________-_+
INFANT : 2.93E-06 : 2.93E-06 : 2.57E-08 : 2.96E-06 : 2.96E-06 : 9.65E-06 : 2.92E-06 : 2.92E-06
-________+______-___+__________+_________-+________-_+________-_+________-_+________-_+________-_+
IV-8
TABLE IV-A-5 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
5 RES AT 4.67 MILES E ANNUALBETAAIRDOSE = 5.64E-05 MILLRADS ANNUALGAMMAAIRDOSE = 2.33E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
______-__+-_________+________-_+_________-+__________+______-_-_+________-_+________-_+________-_+
PLUME
- 1.42E-05 : 1.42E-05 : 1.42E-05 : 1.42E-05 : 1.42E-05 : 1.42E-05 : 1.47E-05 : 3.87E-05
_________+__________+__________+__________+__________+__________+__________+--+__-_+-___+-_______+
GROUND
- 2.70E-07 : 2.70E-07 : 2.70E-07 : 2.70E-07 : 2.70E-07 : 2.70E-07 : 2.70E-07 : 3.16E-07
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INHAL ADULT 9.04E-06 9.03E-06 2.79E-08 9.06E-06 9.09E-06 1.69E-05 9.02E-06 9.01E-06
_________+-_________+_______-__+_________-+_________-+-_________+__________+_________-+________-_+
TEEN
- 9.12E-06 : 9.11E-06 : 3.90E-08 : 9.16E-06 : 9.19E-06 : 1.90E-05 : 9.10E-06 : 9.10E-06
_________+-_________+_________-+_________-+_________-+________-_+________-_+________-_+________-_+
CHILD
- 8.06E-06 : 8.05E-06 : 5.28E-08 : 8.10E-06 : 8.12E-06 : 1.96E-05 : 8.03E-06 : 8.03E-06
_________+______-___+_________-+________-_+________-_+________-_+________-_+________-_+________-_+
INFANT : 4.64E-06 : 4.63E-06 : 4.02E-08 : 4.68E-06 : 4.68E-06 : 1.52E-05 : 4.62E-06 : 4.62E-06
_____-___+-_________+_________-+_________-+________-_+________-_+________-_+________-_+________-_+
IV-9
C C CCe C C C C C C C C C (C C C C C C C ( C ( C-C C C C C C C C C& C C C C C C C ( C TABLE IV-A-6 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
6 RES AT 4.22 MILES ESE ANNUAL BETA AIR DOSE = 1.03E-04 MILLRADS ANNUALGAMMAAIR DOSE = 4.14E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_________+__________+__________+__________+__________+__________+__________+__________+__________+
PLUME
- 2.51E-05 : 2.51E-05 : 2.51E-05 : 2.51E-05 : 2.51E-05 : 2.51E-05 : 2.61E-05 : 6.95E-0S GROUND S.39E-07 5.39E-07 5.39E-07 : 5.39E-07 : 5.39E-07 : 5.39E-07
- 5.39E-07 : 6.30E-07
- INHAL, ADULT 1.66E-05 :1.66E-05 5.05E-08 1.67E-05 1.67E-05 3.09E-05 1.66E-05 1.66E-05 TEEN 1.6BE-05 : 1.68E-05 : 7.06E-08 : 1.68E-05 : 1.69E-05 3.48E-05 : 1.67E-05 : 1.67E-05 CHILD
- 11.48E-05 : 1.48E-05 : 9.54E-08 : 1.49E-OS : 1.49E-05 3.59E-05 : 1.48E-05 : 1.48E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INFANT : 8.53E-06 : 8.51E-06 : 7.26E-08 : 8.60E-06 : 8.60E-06 : 2.78E-05 : 8.50E-06 : 8.50E-06
-________+______-___+_________-+_________-+__________+__________+__________+__________+_________-+
IV-10
TABLE IV-A-7 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
7 RES AT 1.67 MILES SE ANNUALBETAAIRDOSE = 6.56E-04 MILLRLADS ANNUALGAMMAAIRDOSE = 3.97E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_______-_+_-_____-
+__________+_______+_______+_______+----
+
+
_+
PLUME
- 2.50E-04 : 2.50E-04 : 2.50E-04 : 2.50E-04 : 2.50E-04 : 2.50E-04 : 2.56E-04 : 5.75E-04
_________+-_________+_______-__+_________-+________-_+_________-+_______-__+________-_+________-_+
GROUND
- 1.01E-05 : 1.01E-05 : 1.01E-05 : 1.01E-05 : 1.01E-05 : 1.01E-05 : 1.01E-05 : 1.19E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INHAL ADULT 9.36E-05 9.34E-05 4.03E-07 9.40E-05 9.44E-05 1.90E-04 9.33E-05 9.33E-05
_____+___-______+________-_+_________-+________-_+________-_+________-_+________-_+________-_+
TEEN
- 9.45E-05 : 9.44E-05 : 5.61E-07 : 9.52E-05 : 9.57E-05 : 2.17E-04 : 9.41E-05 : 9.41E-05
_________+______-___+_________-+________-_+________-_+________-_+________-_+________-_+________-_+
CHILD
- 8.35E-05 : 8.35E-05 : 7.56E-07 : 8.41E-05 : 8.46E-05 : 2.28E-04 : 8.31E-05 : 8.31E-05
_________+_____-____+_______-__+_________-+________-_+________-_+________-_+________-_+________-_+
INFANT : 4.81E-05 : 4.80E-05 : 5.82E-07 : 4.87E-05 : 4.88E-05 : 1.80E-04 : 4.78E-05 : 4.78E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
IV-ll
C C C C C C (
C CC C-C C C C C ( CC( ( ( ( (C C C C C C C C ( CC C (C C C C C ( C TABLE IV-A-8 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
8 RES AT 0.94 MILES SSE ANNUAL BETA AIR DOSE 2.37E-03 MILLRADS ANNUALGAMMAAIRDOSE = 1.63E-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+___ ___-__+_________-+__________+__________+__________+__________+_____---____-+__-
+
PLUME
- 1.04E-03 : 1.04E-03 : 1.04E-03 : 1.04E-03
- 1.04E-03
- 1.04E-03 : 1.06E-03 : 2.27E-03
-________+______-___+_________-+_________-+________-_+________-_+_________-+________-_+________-_+
GROUND
- 5.03E-05 : 5.03E-05 : 5.03E-05 : 5.03E-05 : 5.03E-05 : 5.03E-OS : 5.03E-05 : 5.88E-05 INHAL ADULT 3.23E-04 3.22E-04 : 1.56E-06 3.24E-04 3.26E-04 6.77E-04 3.21E-04 3.21E-04
-________+_____-____+_________-+_________-+________-_+________-_+________-_+________-_+________-_+
TEEN
- 3;26E-04 : 3.25E-04 : 2.18E-06 : 3.28E-04 : 3.31E-04 : 7.76E-04 : 3.24E-04 :,3.24E-04
-________+__________+__________+__________+__________+__________+__________+_---________-+____-__+
CHILD
- 2.88E-04 : 2.88E-04 : 2.93E-06 : 2.90E-04 : 2.92E-04 : 8.23E-04 : 2.86E-04 : 2.86E-04
-_______+__________+__________+__________+__________+__________+__________+__--________+-________+
INFANT : 1.66E-04 : 1.66E-04 : 2.26E-06 : 1.68E-04 : 1.68E-04 : 6.53E-04 : 1.65E-04 : 1.65E-04
-________+__________+__________+__________+__________+__________+__________+_---________-+____-__+
IV-12
TABLE IV-A-9 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
9 RES AT 0.74 MILES S ANNUALBETAAIRDOSE = 2.93E-03 MILLRADS ANNUALGAMMAAIRDOSE = 1.56E-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_____-___+_-___-____+________-_+________-_+_________-+_________-+_________-+________-_+________-_+
PLUME
- 9.70E-04 : 9.70E-04 : 9.70E-04 : 9.70E-04 : 9.70E-04 : 9.70E-04 : 9.97E-04 : 2.36E-03
________+__________+__________+__________+__________+__________+__________+__________+----_----__
GROUND
- 5.70E-05 : 5.70E-05 : 5.70E-05 : 5.70E-05 : 5.70E-05 : 5.70E-05 : 5.70E-05 : 6.66E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INHAL ADULT 4.37E-04 4.36E-04 1.76E-06 4.38E-04 4.40E-04 8.79E-04 4.35E-04 4.35E-04
_________+____-_____+_________-+________-_+________-_+______-_--+________+_________--_--_________+
TEEN
- 4.41E-04 : 4.40E-04 : 2.46E-06 : 4.44E-04 : 4.46E-04 : 1.OOE-03 : 4.39E-04 : 4.39E-04
_________+-_________+_______-__+________-_+________-_+________-_+________-_+________-_+________-_+
CHILD
- 3.90E-04 : 3.89E-04 : 3.32E-06 : 3.92E-04 : 3.94E-04 : 1.05E-03 : 3.88E-04 : 3.88E-04
__+______-___+_________-+________-_+________-_+________-_+_______-__+________-_+_______-__+
INFANT : 2.24E-04 : 2.24E-04 : 2.54E-06 : 2.27E-04 : 2.27E-04 : 8.27E-04 : 2.23E-04 : 2.23E-04
______-__+_-________+_________-+_________-+________-_+_________-+________-_+________-_+________-_+
IV-13
(
C
(
(((t( C C(
(((
(
C (
l C
C C(
(- (
(((C CCC((C((C c((c
((c'c((
(c
"¢'cc(
TABLE IV-A-10 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
10 RES AT 0.60 MILES SSW ANNUAL BETA AIR DOSE = 2.90E-03 MILLRADS ANNUAL7GAMMAAIRDOSE = 2.OOE-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+ __
_ ___--+__________+__________+__________+__________+__________+______--____+____--_
+
PLUME
- 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.29E-03 : 2.78E-03
_________+__________+__________+__________+__________+__________+__________+__________+__________+-
GROUND 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.71E-05 INHAL ADULT 3.95E-04 3.95E-04 1.95E-06 3.98E-04 4.OOE-04 8.35E-04 3.94E-04 3.94E-04 TEEN 3.99E-04 3.99E-04 : 2.71E-06 : 4.03E-04 : 4.05E-04 : 9.59E-04 : 3.97E-04 : 3.97E-04 CHILD
- 3.53E-04 : 3.53E-04 : 3.64E-06 : 3.56E-04 : 3.58E-04 : 1.02E-03 : 3.51E-04 : 3.51E-04
-________+______-___+_________-+_______-
+----------
+_-________+________-_+________-_+_________-+
INFANT : 2.03E-04 : 2.03E-04 : 2.81E-06 : 2.06E-04 : 2.07E-04 : 8.08E-04 : 2.02E-04 : 2.02E-04
-______-_+__________+_____-_
-__+_______ __-+_--------+----------+-------
+
+
IV-14
TABLE IV-A-11 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
11 RES AT 0.73 MILES SW ANNUAL BETA AIR DOSE = 1.91E-03 MILLRADS ANNUALGAMMA_AIRDOSE = 1.31E-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_______-+__________+__________+__________+__________+__________+__________+--__________+___----__+
PLUME
- 8.35E-04 : 8.35E-04 : 8.35E-04 : 8.35E-04 : 8.35E-04 : 8.35E-04 : 8.51E-04 : 1.83E-03
-_+__________+-
+_
+
__-----+
_+_--___
_+
GROUND
- 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.35E-05
_______-+__________+__________+__________+__________+__________+__________+--__________+__+----__+
INHAL ADULT 2.60E-04 2.60E-04 1.30E-06 2.62E-04 2.63E-04 5.53E-04 2.59E-04 2.59E-04
--+ -
+-
+
+
TEEN
- 2.63E-04 : 2.62E-04 : 1.81E-06 : 2.65E-04 : 2.67E-04 : 6.36E-04 : 2.61E-04 : 2.61E-04
--+-------+-
+-------------------+-
+
+
CHILD
- 2.32E-04 : 2.32E-04 : 2.43E-06 : 2.34E-04 : 2.36E-04 : 6.75E-04 : 2.31E-04 : 2.31E-04
--+-------+-
+-------------------+-
+
+
+--
INFANT : 1.34E-04 : 1.34E-04 : 1.88E-06 : 1.36E-04 : 1.36E-04 : 5.37E-04 : 1.33E-04 : 1.33E-04
+---I-15------+
-+
IV-15
(
( (7 (
(
(
(
( (
(
(I
(.
(
(
(
(
(
(
( ( (
(
(
(
( (
( (
(
' (' ( (
(
i
( (
(
(
(
( (
(C c C C (C (CC (
r C C ( C (
C C C C( (
- cCCC TABLE IV-A-12 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
12 RES AT 1.06 MILES WSW ANNUALBETAAIRDOSE = 9.93E-04 MILLRADS ANNUALGAMMAAIRDOSE = 6.83E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+__ _ ___--+_________-+__________+__________+__________+__________+______--____+____--_
+
PLUME
- 4.34E-04 : 4.34E-04 : 4.34E-04 : 4.34E-04 : 4.34E-04 : 4.34E-04 : 4.43E-04 : 9.51E-04
_________+
7---------------------------------------------------------------------------------------
GROUND 1.05E-05 :1.05E-05 : 1.05E-05 : 1.05E-05 : 1.05E-05 : 1.05E-0S 1.05E-05 : 1.22E-05 INHAL ADULT 1.35E-04 1.35E-04 6.46E-07 1.36E-04 1.37E-04 2.82E-04 1.35E-04 1.35E-04
-________+__________+__________+___-
_-____+__-_______+________-_+_________-+_______-__+______-+
TEEN 1.37E-04 : 1.36E-04 : 8.99E-07 : 1.38E-04 : 1.39E-04 : 3.23E-04 : 1.36E-04 : 1.36E-04
-________+______-___+_________-+_________-+________-_+________-_+________-_+________-_+________-_+
CHILD
- 1.21E-04 : 1.21E-04 : 1.21E-06 1.22E-04 : 1.22E-04 : 3.42E-04 : 1.20E-04 : 1.20E-04
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INFANT : 6.95E-05 :-6.95E-0S : 9.34E-07 : 7.05E-05 : 7.06E-05 : 2.71E-04 : 6.91E-05 : 6.90E-05
-________+______-___+_________-+__________+_________-+_______-__+_______-__+_______-__+________-_+
IV-16
TABLE IV-A-13 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
13 RES AT 1.20 MILES W ANNUALBETAAIRDOSE = 9.93E-04 MILLRADS ANNUALGAMMAAIRDOSE = 6.83E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+______-___+________-_+_________-+_________-+__________+__________+__________+_________-+
PLUME
- 4.34E-04 : 4.34E-04 : 4.34E-04
- 4.34E-04
- 4.34E-04
- 4.34E-04 : 4.43E-04 : 9.51E-04
-_____--___+__________+_________+__________+_________+__________+__________+--__-__-___+-________+
GROUND
- 8.86E-06 : 8.86E-06 : 8.86E-06 : 8.86E-06 : 8.86E-06 : 8.86E-06 : 8.86E-06 : 1.04E-05
_________+__________+__________+__________+__________+__________+__________+__________+___--______+
INHAL ADULT 1.35E-04 1.35E-04 6.46E-07 1.36E-04 1.37E-04 2.82E-04 1.35E-04 1.35E-04
-________+__________+__________+__________+__________+__________+__________+_---________-+____-___
TEEN
- 1.37E-04 : 1.36E-04 : 8.99E-07 : 1.38E-04 : 1.39E-04 : 3.23E-04 : 1.36E-04 : 1.36E-04
-_-______+__________+__________+__________+__________+__________+_________+__--________+-_________
CHILD
- 1.21E-04 : 1.21E-04 : 1.21E-06 : 1.22E-04 : 1.22E-04 : 3.42E-04 : 1.20E-04 : 1.20E-04
-________+__________+__________+__________+__________+__________+__________+_---________-+____-__+
INFANT : 6.95E-05 : 6.95E-05 : 9.34E-07 : 7.05E-05 : 7.06E-05 : 2.71E-04 : 6.91E-05 : 6.90E-05
-________+______-___+__________+_________-+_______-__+________-_+________-_+________-_+________-_+
IV-17
(
(
K (
(
(
(
(
(
(
V C C
(
(
C C C (
(
(
(I
(
C
(
(
(
(
(
(
(
(
(
(
(
(
k K (
CCC~CCCC CCC~(CCC~CCCCCC CC((CC (CCCCC(CCCCCC TABLE IV-A-14 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
14 RES AT 2.26 MILES WNW ANNUALBETAAIRDOSE = 3.83E-04 MILLRADS ANNUALGAMMAAIRDOSE = 2.14E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+__________+__________+__________+__________+__________+__________+_---+-______-+___-___+
PLUME
- 1.34E-04 : 1.34E-04 : 1.34E-04 : 1.34E-04 : 1.34E-04 : 1.34E-04 : 1.38E-04 : 3.19E-04
-________+__________+__________+__________+__________+__________+__________+_---________-+____-__+
GROUND
- 2.37E-06 : 2.37E-06 : 2.37E-06 : 2.37E-06 : 2.37E-06 : 2.37E-06 : 2.37E-06 : 2.77E-06
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INHAL ADULT :5.61E-05: 5.60E-0S.: 2.26E-07 5.64E-05 5.66E-05 1.12E-04 5.60E-05 5.60E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
TEEN
- 5.67E-05 : 5.66E-05 : 3.15E-07 : 5.70E-05 : 5.73E-05 : 1.27E-04 : 5.65E-05 : 5.65E-05 CHILD
- 5.01E-05 : 5.01E-05 : 4.24E-07 :.5.04E-05 5.07E-05 : 1.34E-04 : 4.99E-05 : 4.99E-05
_________+__________+__________+__________+__________+_____-____+____-_____+__________+__________+
INFANT : 2.88E-05 : 2.88E-05 : 3.26E-07 : 2.92E-05 : 2.92E-05 : 1.05E-04 : 2.87E-05 : 2.87E-05
-________+______-___+_________-+__________+_________-+________-_+________-_+________-_+________-_+
IV-18
TABLE IV-A-15 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
15 RES AT 2.40 MILES NW ANNUALBETA AIRDOSE = 4.30E-04 MILLRADS ANNUALGAMMA_AIRDOSE = 2.13E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-_______+ _
__-+
_________-+
__________+__________+__________+__________+______--____+____--_____
PLUME
- 1.32E-04 : 1.32E-04 : 1.32E-04 : 1.32E-04 : 1.32E-04 : 1.32E-04 : 1.36E-04 : 3.30E-04
-________+______-___+__________+__________+__________+__________+__________-----___-___-+____-___+
GROUND
- 2.93E-06 : 2.93E-06 : 2.93E-06 : 2.93E-06 : 2.93E-06 : 2.93E-06 : 2.93E-06 : 3.43E-06
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INHAL ADULT 6.55E-05 6.54E-05 2.40E-07 6.57E-05 6.59E-05 1.28E-04 6.53E-05 6.53E-05
-_____--___+__________+_________+__________+_________+__________+__________+--__-__-___+-________+
TEEN
- 6.61E-05 : 6.60E-05 : 3.35E-07 : 6.65E-05 : 6.68E-05 : 1.45E-04 : 6.59E-05 : 6.59E-05
-________+__________+________-_+________-_+-_________+__________+-_________+__________+________+--
CHILD
- 5.84E-05 : 5.84E-05 : 4.52E-07 : 5.87E-05 : 5.90E-05 : 1.51E-04 : 5.82E-05 : 5.82E-05
-________+______-___+________-_+_________-+________-_+________-_+__________+-_________+________+--
INFANT : 3.36E-05 : 3.36E-05 : 3.46E-07 : 3.40E-05 : 3.40E-05 : 1.18E-04 : 3.35E-05 : 3.35E-05
_________+-_________+__________+__________+__________+__________+__________+__________+__________+
IV-l9 (7 ( C (
(7 ~ ' ( ( '
(
~ ( C ~ ( ( (. (
( C (~ ~
7 (
~ (
k
- (
(
(
(
TABLE IV-A-16 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
16 RES AT 2.08 MILES NNW ANNUAL BETAAIR DOSE = 4.45E-04 MILLRADS ANNUAL7GAMMAAIRDOSE = 2.22E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+___ ___-__+_________-+__________+__________+__________+__________+_____---____-+__-
+
PLUME
- 1.37E-04
- 1.37E-04
- 1.37E-04
- 1.37E-04 : 1.37E-04 : 1.37E-04
- 1.42E-04
- 3.43E-04
-________+______-___+__________+_________-+_________-+________-_+________-_+________-_+________-_+
GROUND
- 5.48E-06 : 5.48E-06 : 5.48E-06 : 5.48E-06 : 5.48E-06 : 5.48E-06 : 5.48E-06
- 6.40E-06
-________+_____-____+_________-+_________-+__________+_________-+________-_+________-_+_______-_+
INHAL:
ADULT 6.76E-05 6.75E-05 2.50E-07 6.78E-05 6.80E-05 1.32E-04 6.74E-05 6.74E-05 TEEN 6.82E-05 : 6.81E-05 : 3.49E-07 : 6.86E-05 6.89E-05 1.SOE-04 : 6.80E-0S : 6.80E-0S CHILD
- 6.03E-05 : 6.02E-05 : 4.71E-07 : 6.06E-05 : 6.09E-05 1.57E-04 : 6.OOE-0S : 6.OOE-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
INFANT : 3.47E-O5 : 3.46E-OS : 3.61E-07 : 3.SOE-OS : 3.S1E-0S : 1.23E 704 : 3.45E-OS : 3.45E-OS
-________+______-___+_________-+________-_+________-_+________-_+________-_+________-_+________-_+
IV-20
TABLE IV-A-17 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
17 VEG AT 3.29 MILES NE ANNUAL BETA AIR DOSE = 6.86E-05 MILLRADS ANNUAL_GAMMAAIRDOSE = 3.44E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_______-_+__________+-
+___
_+
+
-+
__+
PLUME
- 2.13E-05 : 2.13E-05 : 2.13E-05 : 2.13E-05 : 2.13E-05 : 2.13E-05 : 2.20E-05 : 5.32E-05
_______-__+________+________-_+_________-+________-_+________-_+________-_+_________--+
_+
GROUND
- 6.07E-07 : 6.07E-07 : 6.07E-07 : 6.07E-07 : 6.07E-07 : 6.07E-07 : 6.07E-07 : 7.09E-07
_________+__________+__________+__________+__________+__________+__________+__________+__________+
VEGET ADULT 1.93E-05 1.89E-05 5.51E-07 1.96E-05 1.95E-05 1.27E-04 1.88E-05 1.88E-05
_________+_-________+__________+__________+__________+__________+________----+-_________+_____-__+
TEEN
- 2.20E-05 : 2.16E-05 : 8.35E-07 : 2.27E-05 : 2.25E-05 : 1.57E-04 : 2.16E-05 : 2.15E-05
_______-+-_________+__________+__________+__________+___---_-_-
+__-
_______+________--_--+
_+
CHILD
- 3.40E-05 : 3.34E-05 : 1.94E-06 : 3.54E-05 : 3.50E-05 : 2.87E-04 : 3.35E-05 : 3.33E-05
_______-+-_________+_______-__+________-_+_______-__+________-_+________-_+________--_--+
_+
IV-21
( (
(
(
(
( (
(
(,(
(
(
(. ( (
(
(
(
( k (
(
(.(
(
(
(
(
k (
(
(
(
(
(
(
k
(
CCCCC(cCCC(C(CC(CC(CCCCC(CCCC(CCCEecC(C~CCCC TABLE IV-A-18 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
18 VEG AT 4.67 MILES E ANNUAL BETAAIR DOSE = 5.64E-05 MILLRADS ANNUALGAMMA_AIR_DOSE = 2.33E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+__ _ ___--+_________-+__________+__________+__________+__________+______--____+____--_
+
PLUME
- 1.42E-05 : 1.42E-05 : 1.42E-05 : 1.42E-05 : 1.42E-05 : 1.42E-05
- 1.47E-05 : 3.87E-05 GROUND
- 2.70E-07 : 2.70E-07 : 2.70E-07
- 2.70E-07 : 2.70E-07 : 2.70E-07
- 2.70E-07
- 3.16E-07
_________+__________+__________+__________+__________+__________+__________+__________+__________+
VEGET ADULT
- 1.66E-05 1.64E-05 2.48E-07 1.67E-05 1.67E-05 6.48E-05 1.64E-05 1.63E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
TEEN
- 1.89E-05 : 1.87E-05 : 3.76E-07 : 1.92E-05 : 1.92E-05 : 7.95E-05 : 1.87E-05 : 1.87E-05 CHILD
- 2.93E-05 : 2.90E-05 : 8.71E-07 : 3.00E-05 : 2.98E-05 : 1.43E-04 : 2.91E-05 : 2.90E-05
-________+______-___+_________-+_________-+__________+__________+__________+__________+_________-+
IV-22
TABLE IV-A-19 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
19 VEG AT 1.74 MILES SE ANNUALBETAAIRDOSE = 6.10E-04 MILLRADS ANNUAL_GAMMAAIRDOSE = 3.66E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_________+__________+__________+_________+__________+__________+________--_+__________+_--_--____+
PLUME
- 2.30E-04 : 2.30E-04 : 2.30E-04 : 2.30E-04 : 2.30E-04 : 2.30E-04 : 2.36E-04 : 5.32E-04
_______+--__--______+__________+__________+__________+____---____-+__--______+________---_--____+
GROUND
- 9.34E-06 : 9.34E-06 : 9.34E-06 : 9.34E-06 : 9.34E-06 : 9.34E-06 : 9.34E-06 : 1.09E-05
_______-_+__________+-
+__
+
+
_+
+
___-------_+_______- -
VEGET ADULT 1.66E-04 1.59E-04 8.37E-06 1.71E-04 1.69E-04 1.81E-03 1.59E-04 1.58E-04
+
+
4
-+------
TEEN
- 1.89E-04 : 1.82E-04 : 1.27E-05 : 2.OOE-04 : 1.97E-04 : 2.25E-03 : 1.82E-04 : 1.80E-04 CHILD
- 2.90E-04 : 2.81E-04 : 2.94E-05 : 3.12E-04 : 3.06E-04 : 4.15E-03 : 2.82E-04 : 2.80E-04
______-__+_-______+_________-+_________-+________-_+________-_+________-_+__________-+_______----_
IV-23 C C C C C k-C C C C (
C C C ( -
C (- (-(
(.(-(-
(.(-c
(-(
k, (
(
(. k (
k (
(
(
(
(
(
(
(
(
C
( c C(
(((("CCC CC((((((CC(CCCC(C(CVCCCC(
TABLE IV-A-20 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
20 VEG AT 0.94 MILES SSE ANNUAL BETA AIR DOSE = 2.37E-03 MILLRADS ANNUALGAMMAAIRDOSE = 1.63E-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+__ _ ___--+_________-+__________+__________+__________+__________+______--____+____--_
+
PLUME
- 1.04E-03
- 1.04E-03
- 1.04E-03
- 1.04E-03 : 1.04E-03 : 1.04E-03
- 1.06E-03
- 2.27E-03
_________+__________+__________+__________+__________+__________+__________+__________+__________+
GROUND
- S.03E-05 : 5.03E-05
- 5.03E-05 : 5.03E-05 : 5.03E-05 : 5.03E-05 : 5.03E-05
- 5.88E-05 VEGET ADULT 6.28E-04 5.90PE-04 4.46E-05 6.51E-04 6.43E-04 9.39E-03 5.87E-04 5.82E-04
-________+ __________+__________+__________+__________+__________+__________+----
_______+_- ___
+
TEEN 7.11E-04 : 6.74E-04 : 6.76E-05 : 7.68E-04 : 7.53E-04
- 1.17E-02 6.74E-04
- 6.66E-04
-________+ _______
__+__________+__________+__-_-_____+__________+__________+_____----------
+-
+
CHILD
- 1.09E-03 1.04E-03 : 1.57E-04
- 1.20E-03 : 1.17E-03 : 2.17E-02 : 1.05E-03
- 1.03E-03
-________+______-___+_________-+________-_+_______-__+_______-__+________-_+_______-__+________-_+
IV-24
TABLE IV-A-21 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
21 VEG AT 0.74 MILES S ANNUALBETAAIRDOSE = 2.93E-03 MILLRADS ANNUAL_GAMMAAIRDOSE = 1.56E-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
+_- _____
_ + ________-_+ __________+__________+__________+__________+______--____+____--_
+
PLUME
- 9.70E-04 : 9.70E-04 : 9.70E-04 : 9.70E-04 : 9.70E-04 : 9.70E-04 : 9.97E-04 : 2.36E-03
_____-_--_+-_____-+___-______+________-_+_________-+__________+-__________+______---__+-_________+
GROUND
- 5.70E-05 : 5.70E-05 : 5.70E-05 : 5.70E-05 : 5.70E-05 : 5.70E-05 : 5.70E-05 : 6.66E-05
_________+__________+__________+__________+__________+__________+__________+__________+______-__-+
VEGET ADULT 8.41E-04 7.98E-04 5.16E-05 8.69E-04 8.58E-04 1.09E-02 7.94E-04 7.88E-04
_________+-_________+_______-__+________-_+________-_+________-_+________-_+________-_+________-_+
TEEN
- 9.55E-04 : 9.12E-04 : 7.82E-05 : 1.02E-03 : 1.OOE-03 : 1.36E-02 : 9.11E-04 : 9.02E-04
_________+______-___+_________-+________-_+_________-+_________-+________-_+________-_+________-_+
CHILD
- 1.46E-03 : 1.41E-03 : 1.81E-04 : 1.60E-03 : 1.56E-03 : 2.52E-02 : 1.41E-03 : 1.40E-03
_____-_+-_________+_________-+_________-+_________-+_________-+__________+_________-+_________-+
IV-25 (7 C C C ( C C k- (-C ( C (- C (,- C C (
( C C C ( ("- ( C (
- (
( (, k (
(
(
(
( (
(
(
(
(
(
TABLE IV-A-22 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
22 VEG AT 0.60 MILES SSW ANNUAL BETA AIR DOSE = 2.90E-03 MILLRADS ANNUALGAMMA_AIR DOSE = 2.OOE-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+______-___+_________-+_________-+________-_+_________-+_________-+_________-+________-_+
PLUME
- 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.29E-03 : 2.78E-03
-________+______-___+_________-+-_________+_________-+_______-__+________-_+________-_+________-_+
GROUND
- 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.71E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
VEGET ADULT 7.50E-04 7.20E-04 i 3.57E-05 7.69E-04 7.62E-04 7.76E-03 7.17E-04 7.13E-04
-________+___- _____+-_________+______-___+________-_+________-_+________-_+________-_+________-_+
TEEN 8.52E-04 : 8.23E-04 : 5.41E-05 : 8.98E-04 : 8.85E-04 : 9.66E-03 : 8.22E-04 : 8.16E-04
-________+______-___+_________-+
-_________+___-______+_________-+________-_+________-_+________-_+
CHILD
- 1.31E-03 : 1.27E-03 : 1.25E-04 : 1.40E-03 : 1.38E-03 : 1.78E-02 : 1.28E-03 : 1.27E-03
-________+______-___+_________-+________-_+________-_+________-_+________-_+________-_+________-_+
IV-26
TABLE IV-A-23 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
23 VEG AT 1.31 MILES SW ANNUALBETAAIRDOSE = 4.43E-04 MILLRADS ANNUALGAMMAAIRDOSE = 3.05E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
+-
+------
+
+
PLUME
- 1.94E-04 :1.94E-04 :1.94E-04 :1.94E-04 :1.94E-04 :1.94E-04 :1.98E-04 :4.24E-04
-+------------+-
+-------------------+-
+
+
+--
GROUND
- 4.63E-06
- 4.63E-06 :4.63E-06 :4.63E-06 :4.63E-06 :4.63E-06 :4.63E-06 :5.41E-06
-+--
I-
+
-+
+-
VEGET ADULT 1.13E-04 1.10E-04 4.10E-06 1.15E-04 1.14E-04 9.19E-04 1.09E-04 1.095-04
+
+-
++
+---+--+-----
TEEN
- 1.295-04 :1.25E-04 :6.22E-06 :1.34E-04 :1.33E-04 :1.14E-03 :1.25E-04 :1.25E-04
+
+-
++
+---+--+-----
CHILD
- 1.985-04 :1.94E-04 :1.445-05 :2.09E-04 :2.065-04 :2.09E-03 :1.95E-04 :1.935-04
+
+-
++
++
+--+-----
IV-27 C( CC C
( CC (
( (CC (C
C(
((
CCC CCCC cCc(CCC (C (C(( C((C(CC (CCCCCCC CC C CCC((((((C (CC(CC(
TABLE IV-A-24 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
24 VEG AT 1.21 MILES WSW ANNUAL BETA AIR DOSE = 6.56E-04 MILLRADS ANNUALGAMMAAIRDOSE = 3.97E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_________+__________+__________+__________+__________+__________+__________+__________+__________+
PLUME
- 2.50E-04 : 2.SOE-04 : 2.50E-04 : 2.S0E-04 : 2.50E-04 : 2.50E-04 : 2.56E-04 : 5.75E-04 GROUND
- 6.96E-06 : 6.96E-06 : 6.96E-06 : 6.96E-06 : 6.96E-06 : 6.96E-06 : 6.96E-06 : 8.13E-06
+
_----+-___---_--+-__------_+
-____-----+-----_-__+-_-+-_-+
VEGET ADULT 1.75E-04 1.70E-04 6.23E-06 1.79E-04 1.77E-04 1.40E-03 1.70E-04 1.69E-04
__+_____-____+___-
+-_________+_____-____+________-_+________-_+________-_+________-_+
TEEN
- 2.00E-04 : 1.94E-04 : 9.45E-06 : 2.08E-04 : 2.05E-04 :'1.74E-03 : 1.94E-04 : 1.93E-04
-________+______-___+________- +-_________+______-___+________-_+__________-+_________+_________-+
CHILD
- 3.08E-04 : 3.01E-04 : 2.19E-05 : 3.24E-04 : 3.19E-04 : 3.18E-03 : 3.02E-04 : 3.00E-04
-________+______-___+_________-+________-_+________-_+________-_+________-_+________-_+________-_+
IV-28
TABLE IV-A-25 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
25 VEG AT 1.20 MILES W ANNUALBETAAIRDOSE = 9.93E-04 MILLRADS ANNUALGAMMAAIRDOSE = 6.83E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+__________+-
+___
_+
__-----+
-_+_--____
_+
PLUME
- 4.34E-04 : 4.34E-04 : 4.34E-04 : 4.34E-04 : 4.34E-04 : 4.34E-04 : 4.43E-04 : 9.51E-04
-________+__________+-
+ __________+__________+__________+__________+_____--_____+____--_
_ +
GROUND
- 8.86E-06 : 8.86E-06 : 8.86E-06 : 8.86E-06 : 8.86E-06 : 8.86E-06 : 8.86E-06 : 1.04E-05
-________+_________+__________+_________+__________+_____--_____+____--_____+_________------_____+
VEGET ADULT 2.52E-04 2.46E-04 7.85E-06 2.56E-04 2.55E-04 1.79E-03 2.45E-04 2.44E-04
+-----------------+
+---------
-- 4---------
+-----
TEEN
- 2.87E-04 : 2.81E-04 : 1.19E-05 : 2.97E-04 : 2.94E-04 : 2.22E-03 : 2.81E-04 : 2.79E-04 CHILD
- 4.43E-04 : 4.35E-04 : 2.76E-05 : 4.63E-04 : 4.58E-04 : 4.07E-03 : 4.36E-04 : 4.34E-04
-_-______+_____-____+_________-+________-_+________-_+________-_+________-_+________-_+_______-__+
IV-29
(* ( ( (
( .(- k..(.
( (-(...-
(.(.
(.-(
(
(.(.
(
(.(.
. (
(
(
(
(
(
(
(
(
(
(
(
C(((C (CCCCc((
((CC(C((
C(CCCe C(C(CCCCCC(C TABLE IV-A-26 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
26 VEG AT 2.97 MILES WNW ANNUAL BETA AIR DOSE = 1.75E-04 MILLRADS ANNUAL7GAMMA_AIRDOSE = 8.18E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+______--+_________-+__________+__________+__________+__________+______--____++___--____+
PLUME
- 5.04E-05
- 5.04E-05 : 5.04E-05 : 5.04E-05 : 5.04E-05 : 5.04E-05 : 5.20E-05 : 1.30E-04
-________+______-___+________-_+________-_+________-_+_________-+__________+-_________+_________-+
GROUND
- 1.01E-06 : 1.01E-06 : 1.01E-06 : 1.01E-06 : 1.01E-06 : 1.01E-06 : 1.01E-06 : 1.18E-06
_________+__________+__________+__________+__________+__________+__________+__________+__________+
VEGET ADULT 4.98E-05 4.90E-05 9.23E-07 5.02E-05 5.01E-0S 2.30E-04 4.89E-05 4.88E-05 TEEN 5.68E-05 5.60E-05 : 1.40E-06 : 5.79E-05 : 5.76E-0S : 2.83E-04 : 5.60E-05 : 5.58E-05 CHILD
- 8.78E-05 8.68E-OS : 3.24E-06 : 9.02E-05 : 8.95E-05 : 5.12E-04 : 8.70E-05 : 8.67E-05
-________+_____-____+_________-+________-_+________-_+________-_+________-_+________-_+_____+
IV-30
TABLE IV-A-27 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
27 VEG AT 2.40 MILES NW ANNUALBETAAIRDOSE = 4.30E-04 MILLRADS ANNUALGAMMAAIRDOSE = 2.13E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_______-_+-_________+_________-+__________+__________+__________+__________+____---+____+___--___+
PLUME
- 1.32E-04 : 1.32E-04 : 1.32E-04 : 1.32E-04 : 1.32E-04 : 1.32E-04 : 1.36E-04 : 3.30E-04
_______-.+_---______+___-______+________-_+_________-+________-_+________-_+________-_+________-_+
GROUND
- 2.93E-06 : 2.93E-06 : 2.93E-06 : 2.93E-06 : 2.93E-06 : 2.93E-06 : 2.93E-06 : 3.43E-06
_________+__________+__________+__________+__________+__________+__________+__________+__________+
VEGET ADULT 1.21E-04 1.19E-04 2.66E-06 1.22E-04 1.22E-04 6.41E-04 1.19E-04 1.18E-04
_________+______-___+________-_+________-_+________-_+________-_+________-_+_________-+_________-+
TEEN
- 1.38E-04 : 1.36E-04 : 4.04E-06 : 1.41E-04 : 1.40E-04 : 7.92E-04 : 1.36E-04 : 1.35E-04
_________+-_________+________-_+________-_+________-_+________-_+________-_+_________-+_________-+
CHILD
- 2.13E-04 : 2.10E-04 : 9.37E-06 : 2.20E-04 : 2.18E-04 : 1.44E-03 : 2.11E-04 : 2.10E-04
______-__+-_________+_________-+_________-+________-_+________-_+________-_+________-_+________-_+
IV-31
(
(
CC (
(7 "
C C C C-C C C ( C C ( C ( C C C ( C ( C C C C C C C C C C C C C-C C C C C TABLE IV-A-28 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
28 VEG AT 4.01 MILES NNW ANNUALBETA AIR DOSE = 1.03E-04 MILLRADS ANNUAL7GAMMAAIRDOSE = 4.14E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+ __
_ ___--+__________+__________+__________+__________+__________+______--____+____--_
+
PLUME
- 2.51E-05 : 2.51E-05 : 2.51E-05 : 2.51E-05 : 2.51E-05 : 2.51E-05
- 2.61E-05
- 6.95E-05 GROUND
- 1.06E-06 : 1.06E-06 : 1.06E-06 : 1.06E-06 : 1.06E-06 : 1.06E-06 : 1.06E-06 : 1.24E-06
_________+__________+__________+__________+__________+__________+__________+__________+__________+
VEGET ADULT 3.10E-05 :3;02E-05 9.73E-07 3.15E-05 3.13E-05 2.20E-04 :3.01E-05 3.OOE-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+-
TEEN
- 3.53E-05 : 3.45E-05 : 1.48E-06 : 3.66E-05 : 3.62E-05 : 2.73E-04 : 3.45E-05 : 3.44E-05 CHILD
- 5.45E-05 : 5.35E-05 : 3.42E-06 : 5.71E-05 : 5.63E-05 : 4.99E-04 : 5.36E-05 : 5.34E-05
-________+______-___+_________-+_________-+_________-+__________+__________+__________+_________-+
IV-32
TABLE IV-A-29 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
29 BEEF AT 4.72 MILES NNE ANNUALBETAAIRDOSE = 4.37E-05 MILLRADS ANNUAL_GAMMAAIRDOSE = 1.94E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
______-__+-_________+________-_+__--______+__________+__________+__________+_______---_+___--____+
PLUME
- 1.19E-05 : 1.19E-05 : 1.19E-05 : 1.19E-05 : 1.19E-05 : 1.19E-05 : 1.23E-05 : 3.14E-05 GROUND
- 5.04E-07 : 5.04E-07 : 5.04E-07 : 5.04E-07 : 5.04E-07 : 5.04E-07 : 5.04E-07 : 5.89E-07
_________+__________+__________+__________+__________+__________+__________+__________+__________+
MEAT ADULT 1.82E-06 1.78E-06 3.69E-08 1.84E-06 1.82E-06 5.81E-06 1.79E-06 1.78E-06
_________+______-___+_________-+_________-+__________+_-_________+__________+___--+--___+_-______+
TEEN
- 1.08E-06 : 1.06E-06 : 3.03E-08 : 1.11E-06 : 1.09E-06 : 3.98E-06 : 1.07E-06 : 1.06E-06
_________+______-___+_________-+________-_+________-_+________-_+________-_+________-_+________-_+
CHILD
- 1.30E-06 : 1.29E-06 : 5.55E-08 : 1.35E-06 : 1.32E-06 : 5.70E-06 : 1.29E-06 : 1.29E-06
______-__+-_________+_________-+_________-+_________-+_________-+_________-+_________-+________-_+
IV-33
(
(
(
(
(
(
(
k
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
('
(
(
(
( (
(
(
C CC CC CC CC CC CC CC CC CC( C (
C C C C C
C C C(
TABLE IV-A-30 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
30 BEEF AT 4.91 MILES E ANNUAL BETA AIR DOSE = 5.21E-05 MILLRADS ANNUAL7GAMMAAIRDOSE = 2.11E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+__________+__________+__________+__________+__________+__________--+_________+__--+--__+
PLUME
- 1.28E-05 : 1.28E-05 : 1.28E-05 : 1.28E-05 : 1.28E-05 : 1.28E-05 : 1.33E-05 : 3.53E-05
-________+__________+-
+___
_+
__-----+
-___+_--__
_+
GROUND
- 2.50E-07 : 2.50E-07 : 2.50E-07 : 2.50E-07 : 2.50E-07 : 2.50E-07 : 2.50E-07 : 2.93E-07
+-
+-------------------+-
+
+
+--
MEAT ADULT 2.21E-06 2.19E-06: 1.84E-08 2.21E-06 2.20E-06 4.19E-06 2.19E-06 2.19E-06
-____ ___+_____-____+________-_+________-_+_________-+________-_+________-_+________-_+________-_+
TEEN 1.31E-06 : 1.30E-06 : 1.51E-08 : 1.33E-06 : 1.32E-06 : 2.76E-06 : 1.30E-06 : 1.30E-06
-________+______-___+________-_+________-_+________-_+________-_+_________-+_________-+________-_+
CHILD
- 1.59E-06 : 1.58E-06 : 2.77E-08 : 1.61E-06 : 1.60E-06 : 3.77E-06 : 1.58E-06 : 1.58E-06
_+
_+
_+
+
+
_+
-+
+
IV-34
TABLE IV-A-31 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
31 BEEF AT 4.59 MILES SE ANNUALBETAAIRDOSE = 7.06E-05 MILLRADS ANNUALGAMMAAIRDOSE = 3.89E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_______-_+_-_____-
+__________+_______+_______+_______+----
+
+__+
PLUME
- 2.43E-05 : 2.43E-05 : 2.43E-05 : 2.43E-05 : 2.43E-05 : 2.43E-05 : 2.50E-05 : 5.82E-05
_________+______-___+__________+__________+__________+__________+__________+_---___-___-+____-___+
GROUND
- 8.48E-07 : 8.48E-07 : 8.48E-07 : 8.48E-07 : 8.48E-07 : 8.48E-07 8.48E-07 : 9.91E-07
_________+__________+__________+__________+__________+__________+________------_---+_______+__-__+
MEAT ADULT 2.77E-06 2.71E-06 6.11E-08 2.80E-06 2.76E-06 9.42E-06 2.71E-06 2.70E-06
_________+-_________+_______-__+________-_+________-_+________-_+________-_+________-_+________-_+
TEEN
- 1.64E-06 : 1.61E-06 : 5.02E-08 : 1.69E-06 : 1.66E-06 : 6.47E-06 : 1.62E-06 : 1.61E-06
_________+-_________+_________-+_________-+________-_+_________-+________-_+________-_+________-_+
CHILD
- 1.97E-06 : 1.95E-06 : 9.19E-08 : 2.05E-06 : 2.01E-06 : 9.30E-06 : 1.96E-06 : 1.95E-06
_____-___+-_________+________-_+_________-+_________-+_________-+__________+_________-+________-_+
IV-35
( C C C C C C ( C C C C (' ( ( C C ( C C C C ( C C C C C C (C
C C C C ( C( C C C C C C C c
(
(
TABLE IV-A-32 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
32 BEEF AT 1.82 MILES SSE ANNUAL BETA AIR DOSE = 4.74E-04 MILLRADS ANNUAL7GAMMA_AIRDOSE 2.74E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+___ ___-__+_________-+__________+__________+__________+__________+_____---____-+__-
+
PLUME
- 1.72E-04 : 1.72E-04 : 1.72E-04 : 1.72E-04 : 1.72E-04 : 1.72E-04 : 1.77E-04 : 4.03E-04
-________+______-___+_________-+________-_+_________-+_________-+__________+_________-+________-_+
GROUND
- 9.70E-06 : 9.70E-06 : 9.70E-06 : 9.70E-06 : 9.70E-06 : 9.70E-06 : 9.70E-06 : 1.13E-05 :
_________+__________+__________+__________+__________+__________+__________+__________+__________+
MEAT ADULT*
1.86E-05 1.79E-05 6.96E-07 1.89E-05 : 1.85E-05 9.45E-05 1.79E-05 1.78E-05 TEEN 1.10E-05 1.07E-05 :-5.73E-07 : 1.1SE-05 : 1.12E-05 : 6.62E-05 : 1.07E-05 : 1.06E-05
____+_-_______
+_________-+_____-____+________-_+________-_+________-_+_____-_+__-_+
CHILD
- 1.32E-05 1.29E-05': 1.OSE-06 : 1.40E-05 :,1.36E-05 : 9.67E-05 : 1.30E-05 : 1.29E-05
-________+_______-__+__________+_________-+________-_+________-_+________-_+_________-+________-_+
IV-36
TABLE IV-A-33 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
33 BEEF AT 2.60 MILES S ANNUALBETAAIRDOSE = 1.24E-04 MILLRADS ANNUALGAMMAAIRDOSE = 5.28E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
+__
_______+_-
+___
______+__________+__________+__________+___-----
+_
_+
PLUME
- 3.22E-05 : 3.22E-05 : 3.22E-05 : 3.22E-05 : 3.22E-05 : 3.22E-05 : 3.34E-05 : 8.67E-05
-______+____-
___+__________+___--_--____+__________+--
___+
_______+____--
_+-
________+
GROUND
- 2.13E-06 : 2.13E-06 : 2.13E-06 : 2.13E-06 : 2.13E-06 : 2.13E-06 : 2.13E-06 : 2.48E-06
_______-_+__________+-
+___
_+
__----+
-+
-___+_--__+
MEAT ADULT 5.30E-06 5.14E-06 1.56E-07 5.38E-06 5.28E-06 2.22E-05 5.15E-06 5.13E-06
--+-------+-
+-------------------+-
+
+
+---
TEEN
- 3.14E-06 : 3.07E-06 : 1.28E-07 : 3.25E-06 : 3.18E-06 : 1.54E-05 : 3.07E-06 : 3.05E-06
-+--------+-
+----------------------------+- ----
+
+--
CHILD
- 3.77E-06 : 3.71E-06 : 2.34E-07 : 3.96E-06 : 3.86E-06 : 2.23E-05 : 3.72E-06 : 3.70E-06
+---I-37------------
+
IV-37 K
C K
C(1t (1 C C (I ( ( C C C (I C C- ( C ( Cs ( C Ct C C C. C. C ( C C C C C C C C C C (i C C ( ( C TABLE IV-A-34 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
34 BEEF AT 0.60 MILES SSW ANNUALBETAAIRDOSE = 2.90E-03 MILLRADS ANNUALGAMMAAIRDOSE = 2.OOE-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+__ _ ___--+_________-+__________+__________+__________+__________+______--____+____--_
_ +
PLUME
- 1.27E-03
- 1.27E-03 : 1.27E-03
- 1.27E-03 : 1.27E-03 : 1.27E-03
- 1.29E-03
- 2.78E-03
-________+______-___+_________-+________-_+_________-+-_________+__________+_________-+________-_+
GROUND
- 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.71E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
MEAT.
ADULT 1.O6E-04 1.03E-04 2.84E-06 1.07E-04 1.05E-04 4.17E-04 1.03E-04 1.03E-04 TEEN 6.26E-05 : 6.13E-05 : 2.34E-06 : 6.47E-05 : 6.34E-05 : 2.89E-04
- 6.15E-05 : 6.11E-05 CHILD 7.52E-05 : 7.41E-05 : 4.28E-06 : 7.87E-05 : 7.69E-05 : 4.18E-04 : 7.44E-05 : 7.40E-05
-________+______-___+_________-+_________-+__________+__________+__________+_________-+________-_
+
IV-38
TABLE IV-A-35 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
35 BEEF AT 0.73 MILES SW ANNUALBETAAIR DOSE = 1.91E-03 MILLRADS ANNUALGAMMAAIRDOSE = 1.31E-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_______-+-_________+__________+__________+__________+__________+__________+___--_______--+___-___+
PLUME
- 8.35E-04 : 8.35E-04 : 8.35E-04 : 8.35E-04 : 8.35E-04 : 8.35E-04 : 8.51E-04 : 1.83E-03
+- _________
+__________+______-
-__+__________+_______
__+___
____---___+-_______
+
GROUND
- 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.01E-05 : 2.35E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
MEAT ADULT 6.90E-05 6.76E-05 1.42E-06 6.97E-05 6.89E-05 2.25E-04 6.77E-05 6.75E-05
_________+______-___+________-_+________-_+________-_+________-_+_______-__+________-_+________-_+
TEEN
- 4.10E-05 : 4.03E-05
- 1.17E-06 : 4.20E-05
- 4.13E-05 : 1.54E-04
- 4.04E-05
- 4.02E-05
_________+______-___+_________-+________-_+________-_+________-_+_______-__+________-_+________-_+
CHILD
- 4.93E-05
- 4.87E-05
- 2.14E-06
- 5.11E-05
- 5.01E-05 : 2.21E-04
- 4.89E-05 : 4.87E-05
_____-___+-_________+_________-+_________-+_________-+__________+__________+__________+_________-+
IV-39
(.
(. (-
- (.
(- (.
(- (. (,
(
(-
(,- (
(- (
(
(
(
(
(
(
k
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
(
( C C ( C C
( C C C C C ( C (. C C C (' C C( C C C C C"C C C C C C(C C
C C TABLE IV-A-36 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
36 BEEF AT 2.42 MILES WSW ANNUAL BETA AIR DOSE = 1.30E-04 MILLRADS ANNUALGAMMAAIRDOSE 8.93E-05 MILLRADS PATHWAY T.iBODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+___ ___-__+________-_
+__________+__________+__________+__________+_____---____-+__-
+
PLUME
- 5.68E-05 : 5.68E-05 : 5.68E-05 : 5.68E-OS : 5.68E-05 : 5.68E-05 : 5.79E-05 : 1.24E-04 GROUND
- 1.15E-06 : 1.15E-06 : 1.15E-06 : 1.15E-06 : 1.15E-06 : 1.15E-06 : 1.1SE-06 : 1.34E-06 :
MEAT ADULT 4.68E-06 4.60E-06 8.10E-08 4.72E-06 4.67E-06 1.35E-05 4.60E-06 4.59E-06
-________+______-___+__________+_________-+_________-+
-___+_______-__+_______-__+__-__+
TEEN 2.78E-06 : 2.74E-06 6.67E-08 : 2.84E-06 : 2.80E-06 : 9.22E-06 : 2.74E-06 : 2.73E-06
-________+______-___+_________-+_________-+________-_+________-_+________-_+________-_+________-_+
CHILD
- 3.35E-06 : 3.31E-06 : 1.22E-07 : 3.45E-06 : 3.39E-06 : 1.31E-05 : 3.32E-06 : 3.31E-06 :
-________+______-___+_________-+__________+_________-+_______-__+________-_+________-_+________-_+
IV-40
TABLE IV-A-37 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
37 BEEF AT 3.25 MILES W ANNUALBETAAIRDOSE = 8.19E-05 MILLRADS ANNUALGAMMAAIRDOSE = 3.11E-05 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+ __
___-+
__________+ __________+__________+__________+__________+______--____+____--_
+
PLUME
- 1.87E-05 : 1.87E-05 : 1.87E-05 : 1.87E-05 : 1.87E-05 : 1.87E-05 : 1.95E-05 : 5.34E-05
-________+______-___+_________-+________-_+_________-+________-_+________-_+________-_+________-_+
GROUND
- 6.33E-07 : 6.33E-07 : 6.33E-07 : 6.33E-07 : 6.33E-07 : 6.33E-07 : 6.33E-07 : 7.39E-07
_________+__________+__________+__________+__________+__________+__________+__________+__________+
MEAT ADULT 3.56E-06 3.51E-06 4.67E-08 3.58E-06 3.55E-06 8.58E-06 3.51E-06 3.51E-06
-________+__________+__________+__________+__________+__________+__________--__________+-________+
TEEN
- 2.12E-06 : 2.09E-06 : 3.84E-08 : 2.15E-06 : 2.13E-06 : 5.76E-06 : 2.10E-06 : 2.09E-06
-________+__________+__________+__________+____----+-+-__________+__________+____---___+-________+
CHILD
- 2.55E-06 : 2.53E-06 : 7.02E-08 : 2.61E-06 : 2.58E-06 : 8.08E-06 : 2.54E-06 : 2.53E-06
-________+__________+__________+__________+__________+__________+__________+_---________-+____-__+
IV-41
(
(
(
C (
(
(
f, ( ( ( ( ( ( ( ( ( ;, ( ( (
\\, ( ( ( (
(7'CCCCCC(
"c1C cCc((\\(
(' C C (CC( ( (C
( (CCCC (C (C C(
(( (C C C TABLE IV-A-38 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
38 BEEF AT 2.74 MILES WNW ANNUAL BETA AIR DOSE = 2.19E-04 MILLRADS ANNUALGAMMA_AIRDOSE = 1.09E-04 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
-________+ __
_ ___--+__________+ __________+__________+__________+__________+______--____+____--_
+
PLUME
- 6.73E-05 : 6.73E-05 : 6.73E-05 : 6.73E-05 : 6.73E-05 : 6.73E-05 : 6.93E-05 : 1.68E-04
-________+______-___+_________-+________-_+________-_+________-_+________-_+________-_+________-_+
GROUND 1.29E-06 1.29E-06 1.29E-06 : 1.29E-06 : 1.29E-06 : 1.29E-06 : 1.29E-06 : 1.51E-06 MEAT ADULT 8.74E-06 8.64E-06 9.36E-08 8.78E-06 8.73E-06 1.89E-05 8.65E-06 8.63E-06 TEEN 5.20E-06 : 5.'15E-06 : 7.71E-08 : 5.26E-06 : 5.22E-06 : 1.26E-05 : 5.16E-06 : 5.14E-06 CHILD 6.27E-06 : 6.24E-06 : 1.41E-07 : 6.39E-06 : 6.33E-06 : 1.75E-05 : 6.25E-06 : 6.23E-06
+
+
+
+
+
+
+
+
+
IV-42
TABLE IV-A-39 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS SPECIAL LOCATION NO.
39 GOAT AT 0.60 MILES SSW ANNUALBETAAIRDOSE = 2.90E-03 MILLRADS ANNUAL_GAMMAAIRDOSE = 2.OOE-03 MILLRADS PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
_______-_+-_________+________-_+__________+__________+__________+__________+____---____+___--____+
PLUME
- 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.27E-03 : 1.29E-03 : 2.78E-03
_________+______-___+__________+__________+__________+__________+__________+_---___-___-+____-___+
GROUND
- 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.03E-05 : 4.71E-05
_________+__________+__________+__________+__________+__________+__________+__________+__________+
GOATMILK :
ADULT
- 5.76E-04 5.02E-04 7.82E-05 6.16E-04 5.78E-04 1.10E-02 5.01E-04 4.91E-04
_________+_______-__+_________-+_________-+_________-+________-_+_________-+________-_+_______-__+
TEEN
- 7.33E-04 : 6.54E-04 : 1.41E-04 : 8.57E-04 : 7.92E-04 : 1.73E-02 : 6.60E-04 : 6.39E-04
_________+ ______
___+__
+_____
____+
__+___
___+_---________-+
_ +
CHILD
- 1.12E-03 : 1.02E-03 : 3.37E-04 : 1.38E-03 : 1.27E-03 : 3.41E-02 : 1.04E-03 : 1.01E-03
_________+ ______
___+__
+_____
____+
__+___
___+_---+-______-+
_ +
INFANT : 1.69E-03 : 1.55E-03 : 5.88E-04 : 2.30E-03 : 1.96E-03 : 8.19E-02 : 1.59E-03 : 1.54E-03 IV-43
(-(
(
.(
(
(1..
(
(
( (-(-(.(
( (
(
(
(.(.(
(
(
( ( (
(
(
(
I (
(
k
(
(
(
(
'C c C ( c c (C C C C C C c
(
C C C C C C
(
(
C C C C
(
C C I C C C C ( C C C C ( C TABLE IV-B-1 FORT CALHOUN 1 DOSE CONTRIBUTIONS FROM GASEOUS EFFLUENTS UNRESTRICTED AREA BOUNDARY REQUIRED BY TECHNICAL SPECIFICATION 5.9.4.a.
ANNUAL FOR JANUARY 1, 2003 TO DECEMBER 31, 2003 MAXIMUM SITE BOUNDARY GAMMA AIR DOSE -
MAXIMUM SITE BOUNDARY BETA AIR DOSE -
4.41E-03 MILLRADS 6.79E-03 MILLRADS IV-44
TABLE IV-C-1 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS ALARA ANNUAL INTEGRATED POPULATION DOSE
SUMMARY
(PERSON-REM)
PATHWAY T.BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN
______-__+_-________+________-_+_________-+__________+_________-+________-_+________-_+________-_+
PLUME 1.16E-03 1.16E-03 : 1.16E-03 1.16E-03 1.16E-03 1.16E-03 : 1.24E-03 4.08E-03 28.19%
28.39% :
92.22%
27.94%
28.09%
11.87% :
29.61%
58.11%
_________+-_________+_______-__+________-_+__________-+_________+_________-+________-_+________-_+
GROUND 4.63E-05 4.63E-05 4.63E-05 : 4.63E-05 4.63E-05 : 4.63E-05 4.63E-05 : 5.41E-05 1.12%
1.13%
3.67% :
1.11%
1.12% :
0.47%
1.11% :
0.77%
________+-_________+________-_+________-_+_________-+__________+__________+____--____-+__-_______+
INHAL 1.22E-03 1.22E-03 3.74E-06 1.22E-03 1.22E-03 2.25E-03 1.21E-03
- 1.21E-03 29.45%
29.63%
0.30%
29.26%
29.48%
22.92%
29.09% :
17.30%
_________+______-___+_________-+________-_+________-_+_______-__+________-_+________-_+________-_+
VEGET 1.17E-03 1.16E-03 2.06E-05 : 1.18E-03 1.16E-03 1.24E-03 1.16E-03 1.16E-03 28.29%
28.18%
1.63% :
28.41%
28.10%
12.66%
27.75%
16.46%
_________+__________+__________+____________________+__________+__________+________---_+-____---__
COW MILK 2.71E-04 : 2.59E-04 2.38E-05 2.87E-04 2.84E-04 4.46E-03 : 2.58E-04 2.56E-04 6.57% :
6.31%
1.89%
6.89%
6.85%
45.49% :
6.19%
3.65%
_________+-_________+________-_+________-_+________-_+________-_+__________-+_____---_+-_________+
MEAT 2.64E-04 : 2.61E-04 : 3.88E-06 2.66E-04 2.64E-04 6.47E-04 : 2.61E-04 : 2.60E-04 6.38% :
6.36% :
0.31%
6.39%
6.37%
6.59% :
6.25% :
3.71%
_______-+__________+__________+__________+__________+__________+__________+__--________+-________+
- TOTAL*
4.13E-03 : 4.10E-03
- 1.26E-03
- 4.17E-03 : 4.15E-03 : 9.81E-03 : 4.17E-03 : 7.02E-03
_______-+__________+__________+__________+__________+__________+__________+__--________+-________+
IV-45
(
(
(
(
(
k
(
k
(
(
(
(
(
(
(
(
(
(
(
I
(
(
(
(
(
(
(
(
(
(
(
(
k
SECTION V DOSE FROM LIQUID EFFLUENTS LADTAP II OUTPUT Technical Specification 5.9.4.a January 1, 2003 - December 31, 2003 V-1
Radioactive Effluent Releases - First, Second, Third, and Fourth Quarters 2003 LIQUID EFFLUENTS During the reporting period, a total of 1.06E-01 Curies of radioactive liquid materials less tritium, dissolved noble gases, and alpha was released to the Missouri River at an average concentration of 1.06E-10.pCi/mL..This represents 1.06E-02% of the limits specified in Appendix B to 10 CFR 20 (1.OE-06 pCi/mL for unrestricted areas),
295 Curies of tritium were discharged at an average diluted concentration of 2.47E-07 pCi/mL or 2.47E-02% of ECL.(1.OE-03 pCi/mL). Gross alpha radioactivity released during the reporting period total 5.03E-03 Curies.
Dilution water during the period amounted to 1.1 5E+12 liters, while radioactive liquid waste volume was.1.65E+08 liters.
I i I ;.. !
I I.
I I '.
I I
I I
. I.'
f.
A.
Potential Annual Doses to Individuals from Liquid Releases Total body, skin, and organ mRem for liquid releases were calculated for all significant liquid pathways using the annual configuration of the LADTAP II program.
The inputs to LADTAP II for the annual period from January 1, 2003 through December 31, 2003 were as follows:
(1)
All liquid effluents were as described in Section IV except for entrained noble gases (Ar-41, Xe-131M, Xe-133M, Xe-133, Xe-135M, Xe-135, Kr-85M, Kr-87, and Kr-88)
(2)
An average plant discharge rate of 733.0 cubic feet per second (CFS) was utilized for 2003. The average discharge rate during releases was 678.0 cubic feet per second (CFS).
(3)
Dilution factors (inverse of the mixing ratios) were computed based on Regulatory Guide 1.113 (equation 7 in Section 2.a.1 of Appendix A) for a one dimensional transport model.
(4)
Drinking water transport times of 6.6 hours6.944444e-5 days <br />0.00167 hours <br />9.920635e-6 weeks <br />2.283e-6 months <br /> to the Omaha intake and 7.0 hours0 days <br />0 hours <br />0 weeks <br />0 months <br /> to the Council Bluffs intake for the ALARA doses were used. A transport time of 0.0 was used from the plant to the discharge site.
(5)
A shorewidth factor of 0.2 was used.
(6)
All dose factors, transport times from receptor to individual, and usage factors are defined by Regulatory Guide 1.109 and NUREG-0172.
The discharge site was chosen to present the most conservative estimate of mRem dose for an average adult, teenager, child, and infant. A conservative approach is also presented by the assumption that Omaha and Council Bluffs receive all drinking water from the Missouri River.
B.
Potential Annual Doses to Population from Liquid Releases The LADTAP II program in its annual configuration was also used to calculate to total body and organ doses for the population of 853,274 within a 50-mile radius of the plant (based on the 2000 census). The same input was used as in the individual cases with the addition of the following:
V-3
(1)
Dilution factors and transport times for the pathways of sport fish, commercial fish, recreation and biota were calculated based on a distance of two miles downstream as approximately the distance to the nearest recreation facility - DeSoto National Wildlife Preserve.
(2)
The total fish harvest for both sport and commercial purposes was calculated using an average commercial fish catch for Nebraska.
V4
L AAA DDDD TITTT AAA PPPP L
A A D D
T A
A P
P L
A A D D
T A
A P
P L
AAAAA D D
T AAAAA PPPP L
A A D D
T A
A P
LLLLL A A DDDD T
A A
P IIIII IIIII I
I I
I I
I I
I IIIII IIIII EVALUATION OF RADIATION DOSES FROM RELEASES OF RADIACTIVITY IN NUCLEAR POWER PLANTS LIQUID EFFLUENTS REVISION DATE:
PNL VAX - OCTOBER 1985 FORT CALHOUN ANNUAL 2003, DOSE PROJECTIONS RADIOLOGICAL ASSESSMENT BRANCH DIVISION OF SYSTEMS INTEGRATION U.
S.
NUCLEAR REGULATORY COMMISSION WASHINGTON, D. C.
DATE OF RUN:
9-MAR-04 V-5 (7 C C C (7 C C C C C C C C C C C C C (.-
(
(
C C C
( t
(
(
(
(
I(
(
(
(
(
(
(
(
(
t
( c C C C c c ( C ( C ( c C
( ( ( ( C
(
(*(c C c CC( C (
A D U L T D O S E S PATHWAY FISH DRINKING SHORELINE SWIMMING BOATING TOTAL SKIN 4.09E-05 4.09E-05 BONE 1.14E-02 5.91E-05 3.52E-05 5.42E-07 2.71E-07 1.15E-02 LIVER 1.89E-02 8.29E-04 3.52E-05 5.42E-07 2.71E-07 1.97E-02 DOSE _(MREM TOTAL BODY 1.36E-02 8.09E-04 3.52E-05 5.42E-07 2.71E-07 1.45E-02 PER YEAR INTAKE)
THYROID 2.83E-04 8.47E-04 3.52E-05 5.42E-07 2.71E-07 1.17E-03 KIDNEY 6.66E-03 7.83E-04 3.52E-05 5.42E-07 2.71E-07 7.48E-03 LUNG 2.15E-03 7.61E-04 3.52E-05 5.42E-07 2.71E-07 2.95E-03 GI-LLI 7.68E-03 8.55E-04 3.52E-05 5.42E-07 2.71E-07 8.57E-03 FISH DRINKING SHORELINE SWIMMING BOATING USAGE (KG/YR,HR/YR) 21.0 730.0 12.0 12.0 12.0 DILUTION 7.3 30.8 7.3 7.3 7.3 TIME (HR) 24.00 18.60 0.00 0.00 0.00 SHOREWIDTH FACTOR.0.2 TEENAGER D O S E S PATHWAY FISH DRINKING SHORELINE SWIMMING BOATING TOTAL FISH DRINKING SHORELINE SWIMMING BOATING SKIN 2.28E-04 2.28E-04 USAGE (KG/YR,HR/YR) 16.0 510.0 67.0 67.0 67.0 BONE 1.20E-02 5.65E-05 1.96E-04 3.02E-06 1.51E-06 1.23E-02 DILUTION 7.3 30.8 7.3 7.3 7.3 LIVER 1.94E-02 6.03E-04 1.96E-04 3.02E-06 1.51E-06 2.02E-02
_DOSE__(MREM TOTAL BODY 7.72E-03 5.60E-04 1.96E-04 3.02E-06 1.51E-06 8.49E-03 PER YEAR INTAKE)
THYROID 2.53E-04 6.12E-04 1.96E-04 3.02E-06 1.51E-06 1.07E-03 KIDNEY 6.82E-03 5.59E-04 1.96E-04 3.02E-06 1.51E-06 7.58E-03 LUNG 2.53E-03 5.40E-04 1.96E-04 3.02E-06 1.51E-06 3.27E-03 GI-LLI 5.49E-03 S.98E-04 1.96E-04 3.02E-06 1.51E-06 6.29E-03 TIME(HR) 24.00 18.60 0.00 0.00 0.00 SHOREWIDTH FACTOR=0.2 V-6
C H I L D D O S E S PATHWAY FISH DRINKING SHORELINE SWIMMING BOATING TOTAL SKIN 4.77E-05 4.77E-05 BONE 1.50E-02 1.62E-04 4.11E-05 6.32E-07 3.16E-07 1.52E-02 LIVER 1.71E-02 1.17E-03 4.11E-05 6.32E-07 3.16E-07 1.83E-02 DOSE_ (MREM TOTAL BODY 3.02E-03 1.05E-03 4.11E-05 6.32E-07 3.16E-07 4.11E-03 PER YEAR INTAKE)
THYROID 2.55E-04 1.21E-03 4.11E-05 6.32E-07 3.16E-07 1.51E-03 KIDNEY 5.81E-03 1.08E-03 4.11E-05 6.32E-07 3.16E-07 6.93E-03 LUNG 2.OOE-03 1.04E-03 4.11E-05 6.32E-07 3.16E-07 3.08E-03 GI-LLI 2.02E-03 1.07E-03
- 4. 11E-05 6.32E-07 3.16E-07 3.14E-03 FISH DRINKING SHORELINE SWIMMING BOATING USAGE (KG/YRHR/YR) 6.9 510.0 14.0 14.0 14.0 DILUTION 7.3 30.8 7.3 7.3 7.3 TIME (HR) 24.00 18.60 0.00 0.00 0.00 SHOREWIDTH FACTOR=0.2 I N F A N T D O S E S PATHWAY FISH DRINKING SHORELINE TOTAL SKIN 0.OOE+00 0.OOE+00 BONE 0.OOE+00 1.67E-04 0.OOE+00 1.67E-04 LIVER 0.OOE+00 1.19E-03 0.OOE+00 1.19E-03 DOSE_ (MREM TOTAL BODY 0.OOE+00 1.02E-03 0.OOE+00 1.02E-03 PER YEAR INTAKE)
THYROID 0.OOE+00 1.31E-03 0.OOE+00 1.31E-03 KIDNEY 0.OOE+00 1.06E-03 0.OOE+00 1.06E-03 LUNG 0.OOE+00 1.02E-03 0.OOE+00 1.02E-03 GI-LLI 0.OOE+00 1.03E-03 0.OOE+00 1.03E-03 FISH DRINKING USAGE (KG/YRHR/YR) 0.0 330.0 DILUTION 7.3 30.8 TIME (HR) 24.00 18.60 SHOREWIDTH FACTOR=0.2 V-7
(-(-(-(-k-k-(--(-(-(.
(
(,
(
(
(
(
(
(
(
(
(
(
(
1, (
(
(
(
(, (
(
- 1. (
( (
(
\\1 (
k
CCCCCCCC
(
C CC(
(CC(-(
( (((
( (( ( ((
( ((
( ( ( Cc(
(*( C ( C(
( C LOCATION IS PATHWAY FISH DRINKING SHORELINE SWIMMING BOATING TOTAL SITE DISCHG.
A D U L T D O S E S SKIN 2.99E-04 2.992-04 BONE 8.32E-02 1.82E-03 2.57E-04 3.95E-06 1.98E-06 8.522-02 LIVER 1.38E-01 2.55E-02 2.57E-04 3.95E-06 1.98E-06 1.63E-01 DOSE__(MREM TOTAL BODY 9.95E-02 2.49E-02 2.57E-04 3.95E-06 1.98E-06 1.25E-01 PER YEAR INTAKE)
THYROID 2.07E-03 2.62E-02 2.57E-04 3.95E-06 1.98E-06 2.85E-02
=
KIDNEY 4.86E-02 2.41E-02 2.57E-04 3.95E-06 1.98E-06 7.30E-02 LUNG 1.57E-02 2.34E-02 2.57E-04 3.95E-06 1.98E-06 3.94E-02 GI-LLI 5.61E-02 2.63E-02 2.57E-04 3.95E-06 1.98E-06 8.27E-02 FISH DRINKING SHORELINE SWIMMING BOATING USAGE (KG/YR,HR/YR) 21.0 730.0 12.0 12.0 12.0 DILUTION 1.0 1.0 1.0 1.0 1.0 TIME (HR) 24.00 12.00 0.00 0.00 0.00 SHOREWIDTH FACTOR=0.2 R
D O S-E S TE'ENAGE PATHWAY FISH DRINKING SHORELINE SWIMMING BOATING TOTAL SKIN 1.67E-03 1.67E-03 BONE 8.79E-02 1.74E-03 1.43E-03 2.21E-05 1.10E-05 9.11E-02 LIVER 1.42E-01 1.86E-02 1.43E-03 2.21E-05 1.10E-05 1.62E-01 DOSE _(MREM TOTAL BODY 5.64E-02 1.73E-02 1.43E-03 2.21E-05 1.10E-05 7.51E-02 PER YEAR INTAKE)
THYROID 1.85E-03 1.89E-02 1.43E-03 2.21E-05 1.10E-05 2.22E-02 KIDNEY 4.98E-02 1.72E-02 1.43E-03 2.21E-05 1.10E-05 6.85E-02 LUNG 1.8SE-02 1.66E-02 1.43E-03 2.21E-05 1.10E-05 3.66E-02 GI-LLI 4.01E-02 1.84E-02 1.43E-03 2.21E-05 1.10E-05 6.00E-02 FISH DRINKING SHORELINE SWIMMING BOATING USAGE (KG/YRHR/YR) 16.0 510.0 67.0 67.0 67.0 DILUTION TIME(HR) 1.0 24.00 1.0 12.00 SHOREWIDTH FACTOR=0.2 1.0 1.0 1.0 0.00 0.00 0.00 V-8
LOCATION IS PATHWAY FISH DRINKING SHORELINE SWIMMING BOATING TOTAL SITE DISCHG.
C H I L D D O S E S SKIN 3.48E-04 3.48E-04 BONE 1.09E-01
- 4. 99E-03 3.OOE-04 4.61E-06 2.31E-06 1.15E-01 LIVER 1.25E-01 3.60E-02 3.OOE-04 4.61E-06 2.31E-06 1.61E-01
_DOSE_ (MREM TOTAL BODY 2.20E-02 3.23E-02 3.OOE-04 4.61E-06 2.31E-06 5.46E-02 PER YEAR INTAKE)
THYROID 1.86E-03 3.76E-02 3.OOE-04 4.61E-06 2.31E-06 3.97E-02 KIDNEY 4.24E-02 3.32E-02
- 3. OOE-04 4.61E-06 2.31E-06 7.59E-02 LUNG 1.46E-02 3.19E-02 3.OOE-04 4.61E-06 2.31E-06 4.68E-02 GI-LLI 1.47E-02 3.31E-02
- 3. OOE-04 4.61E-06 2.31E-06 4.82E-02 FISH DRINKING SHORELINE SWIMMING BOATING USAGE (KG/YRHR/YR) 6.9 510.0 14.0 14.0 14.0 I N F A N T DILUTION TIME(HR) 1.0 24.00 1.0 12.00 SHOREWIDTH FACTOR-0.2 1.0 1.0 1.0 0.00 0.00 0.00 D O S E S PATHWAY FISH DRINKING SHORELINE TOTAL SKIN 0.OOE+00 0.OOE+00 BONE 0.OOE 00 5.15E-03 0.OOE+00 5.15E-03 LIVER 0.OOE+00 3.65E-02 0.OOE+00 3.65E-02 DOSE__ (MREM TOTAL BODY 0.OOE+00 3.14E-02 0.OOE+00 3.14E-02 PER YEAR INTAKE)
THYROID 0.OOE+00 4.06E-02 0.OOE+00 4.06E-02 KIDNEY
- 0. 00E+00 3.27E-02 0.OOE+00 3.27E-02 LUNG 0.OOE+00 3.15E-02 0.OOE+00 3.15E-02 GI-LLI 0.OOE+00 3.18E-02 0.OOE+00 3.18E-02 V-9
(
(
7 C
C(
t
(
( C (
(-(-(- - ( C ( C C (, C C (.(.
( (. C ( ( (" ( ( ( ( ( 1. ( ( ( ( ( ( (
((cCccCEC((
( (7CCC(
((C(( ((
C FISH CONSUMPTION POPULATION DOSES PERSON-REM SPORT HARVEST PATHWAY FISH FISH FISH FISH AGE GROUP ADULT TEENAGER CHILD TOTAL
DOSE (PERSON-REM)-------------------------
USAGE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 6.10E+04 3.30E-02 5.46E-02 3.95E-02 6.06E-04 1.92E-02 6.23E-03 1.99E-02 7.12E+03 5.34E-03 8.61E-03 3.43E-03 8.15E-05 3.01E-03 1.12E-03 2.18E-03 4.93E+03 1.07E-02 1.22E-02 2.15E-03 1.30E-04 4.11E-03 1.43E-03 1.29E-03 7.30E+04 4.90E-02 7.53E-02 4.50E-02 8.17E-04 2.63E-02 8.78E-03 2.34E-02 LOCATION DILUTION CATCH TIME(HR)-INCLUDES FOOD PROCESSING TIME OF 1.68E+02 HR 7.30E+00 7.30E+04 1.69E+02 POPULATION=1.24E+04 AVERAGE INDIVIDUAL CONSUMPTION (KG/YR)
ADULT-6.90E+00 TEEN-5.20E+00 CHILD-2.20E+00 COMMERCIAL HARVEST
___________-__---------------DOSE PATHWAY AGE GROUP USAGE BONE
-LIVER TOTAL BODY FISH ADULT 4.18E+06 3.75E-03 6.20E-03 4.48E-03 6 FISH TEENAGER 4.88E+05 6.07E-04 9.78E-04; 3.89E-04 e FISH CHILD 3.38E+05 1.21E-03 1.38E-03 2.44E-04 I FISH TOTAL 5.01E+06 5;57E-03 8.56E-03 5.11E-03 E
(PERSON-REM)-------------------------
THYROID 6.06E-05 8.08E-06 1.28E-05 8.15E-05 KIDNEY 2.17E-03 3.41E-04 4.65E-04 2.98E-03 I
LUNG 7.09E-04 1.27E-04.
1.62E-04 9.98E-04 GI-LLI 2.14E-03 2.35E-04 1.39E-04 2.51E-03 LOCATION DILUTION CATCH TIME(HR)-INCLUDES FOOD PROCESSING 7.30E+00 7.30E+04 2.41E+02 TIME OF 2.40E+02 HR POPULATION-8.53E+05 AVERAGE INDIVIDUAL CONSUMPTION (KG/YR)
ADULT-6.90E+00 TEEN-5.20E+00 CHILD-2.20E+00 V-10
POPULATION WATER CONSUMPTION DOSES SUPPLIER-OMAHA
DOSE (PERSON-REM)-------------------------
PATHWAY AGE GROUP USAGE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI DRINKING ADULT 1.39E+08 1.12E-02 1.58E-01 1.54E-01 1.60E-01 1.49E-01 1.45E-01 1.63E-01 DRINKING TEENAGER l.S1E+07 1.68E-03 1.79E-02 1.66E-02 1.80E-02 1.66E-02 1.60E-02 1.77E-02 DRINKING CHILD 2.48E+07 7.85E-03 5.67E-02 5.09E-02 5.86E-02 5.23E-02 5.03E-02 5.21E-02 DRINKING TOTAL 1.79E+08 2.08E-02 2.32E-01 2.21E-01 2.37E-01 2.18E-01 2.11E-01 2.32E-01 POPULATION-5.29E+05 DILUTION=3.08E+01 TRANSIT TIME=3.06E+01 HR (INCLUDING 24 HR FOR TREATMENT FACILITY)
AVERAGE INDIVIDUAL CONSUMPTION (L/YR)
ADULT=3.70E+02 TEEN=2.60E+02 CHILD=2.60E+02 SUPPLIER-COUNCIL BLUFFS PATHWAY DRINKING DRINKING DRINKING DRINKING AGE GROUP ADULT TEENAGER CHILD TOTAL
DOSE USAGE BONE LIVER TOTAL BODY 2.29E+07 1.82E-03 2.55E-02 2.49E-02 2.49E+06 2.71E-04 2.90E-03 2.69E-03 4.07E+06 1.27E-03 9.17E-03 8.24E-03 2.94E+07 3.36E-03 3.76E-02 3.58E-02 (PERSON-REM)-------------------------
THYROID KIDNEY LUNG GI-LLI 2.60E-02 2.41E-02 2.34E-02 2.63E-02 2.92E-03 2.69E-03 2.59E-03 2.87E-03 9.47E-03 8.46E-03 8.14E-03 8.43E-03 3.84E-02 3.52E-02 3.42E-02 3.76E-02 POPULATION=8.70E+04 DILUTION=3.13E+01 TRANSIT TIME=3.10E+01 HR (INCLUDING 24 HR FOR TREATMENT FACILITY)
AVERAGE INDIVIDUAL CONSUMPTION (L/YR)
ADULT=3.70E+02 TEEN-2.60E+02 CHILD-2.60E+02
CUMULATIVE TOTAL-----
PATHWAY AGE GROUP USAGE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI DRINKING CUMUL TOTAL 2.08E+08 2.41E-02 2.70E-01 2.57E-01 2.75E-01 2.53E-01 2.45E-01 2.70E-01 NEPA DOSES_
NOTE--TOTAL NEPA DOSE INCLUDES SPORT CATCH PATHWAY FISH FISH FISH FISH AGE GROUP ADULT TEENAGER CHILD TOTAL
DOSE (PERSON-REM)-------------------------
USAGE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 1.22E+05 6.59E-02 1.09E-01 7.88E-02 1.14E-03 3.82E-02 1.25E-02 3.87E-02 1.42E+04 1.07E-02 1.72E-02 6.84E-03 1.52E-04 6.OOE-03 2.24E-03 4.24E-03 9.85E+03 2.13E-02 2.43E-02 4.29E-03 2.43E-04 8.20E-03 2.85E-03 2.51E-03 1.46E+05 9.79E-02 1.51E-01 9.OOE-02 1.53E-03 5.24E-02 1.76E-02 4.55E-02 HYDROSPHERE TRITIUM DOSE_
AVERAGE INDIVIDUAL WATER CONSUMPTION = 3.0 L/DAY PATHWAY AGE GROUP USAGE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI WATER TOTAL 2.86E+l1 0.OOE+00 2.25E-03 2.25E-03 2.25E-03 2.25E-03 2.25E-03 2.25E-03 V-ll
(-(-
(-
(-(-
(-(-
(-(,
k" (
C
(
C
(
(
(
C C C
( c c C C C( (C C( C c ( "
(C (
C ( C RECREATION POPULATION DOSES C C C CCC
( ( ( (C C
c (c ( (
LOCATION-DOWN STREAM SWIMMING DILUTION= 7.30E+00 TRANSIT TIME-6.70E-01 HR SWF= 0.2 DOSE (PERSON-REM)
SKIN TOTAL BODY THYROID 1.40E-01 1.20E-01 1.20E-01 PATHWAY AGE GROUP SHORELINE TOTAL POPUL USAGE 4.10E+07 LOCATION-DOWN STREAM SWIMMING DILUTION-7.30E+00 TRANSIT TIME= 6.70E-01 HR DOSE (PERSON-REM)
SKIN TOTAL BODY THYROID 1.B4E-03 1.84E-03 PATHWAY AGE GROUP SWIMMING TOTAL POPUL LOCATION-DOWN STREAM BOATIl DILUTION-7.30E+00 PATHWAY AGE GROUP BOATING TOTAL POPUL USAGE 4.10E+07 TRANSIT TIME-6.70E-01 HR USAGE
- 4. 10E+07 DOSE (PERSON-REM)
SKIN TOTAL BODY THYROID 9.19E-04 9.19E-04 DOSE TO BIOTA MRADS PER YEAR BIOTA DILUTION-1.OOE+00 FISH INVERTEBRATE ALGAE MUSKRAT RACCOON HERON DUCK INTERNAL 5.02E-01 8.12E-01 6.54E-01 1.76E+00 6.66E-01 9.51E+00 1.5SE+00 EXTERNAL 9.40E-01 1.88E+00 2.89E-03 6.26E-01 4.69E-01 6.26E-01 9.39E-01 TRANSIT TOTAL 1.44E+00 2.69E+00 6.57E-01 2.38E+00 1.14E+00 1.01E+01 2.49E+00 TIME=
O.OOE+00 HR V-12
SECTION VI RADIOACTIVE EFFLUENT RELEASES - SOLID RADIOACTIVE WASTE Technical Specifications 5.9.4.a, 5.17.d and 5.18.d January 1, 2003 - December 31, 2003 VI-1
III. RADIOACTIVE EFFLUENT RELEASES-SOLID RADIOACTIVE WASTE EFFLUENT AND,WASTE DISPOSAL REPORT January 1, 2003 through December 31, 2003 SOLID WASTE AND IRRADIATED FUEL SHIPMENTS A.
SOLID WASTE SHIPPED OFFSITE FOR BURIAL OR DISPOSAL (NOT IRRADIATED) 1.
a.
Type of Waste Spent resins, filter sludges, evaporator bottoms, etc.
Month Shipped January February March April May June July August September October November December Number of Shipments 0
0 1
0 0
0 0
. 0
' 0 0
0 0
I 2
0 3
3 3
110 0
. 0 2
~1 6
Volume Cu. Meter 0.OOE+00 0.OOE+00 3.86E+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 3.86E+00 1.24E+00 0.00E+00 2.OOE-02 6.1 OE-01 1.06E+00 0.OOE+00 0.00E+00 0.OOE+00 1.27E+00 8.OOE-02 1.36E+00 7.19E+00 1.28E+01 Curie Content 0.OOE+00 0.OOE+00 1.76E+01 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 1.76E+01 1.09E-02 0.OOE+00 9.80E-06 1.33E-02 4.73E-02 0.OOE+00 0.00E+00 O.OOE+00 1.22E-02 1.44E-02 6.56E-03 1.42E+00 1.53E+00 Est. Total,
- Error N/A N/A 20 N/A N/A NIA NIA N/A N/A N/A N/A-N/A N/A 20 N/A 20 20 20 N/A N/A 20 20 20 20 20 20 Total (Type a)
- b.
Dry compressible, contaminated equipment, etc.
January February March April May June July August September October November December Total (Type b) 21 Vl-2
111.
RADIOACTIVE EFFLUENT RELEASES-SOLID RADIOACTIVE WASTE EFFLUENT AND WASTE DISPOSAL REPORT (continued)
- 1.
Type of Waste
- c.
Irradiated components and other categories Month Shipped January February March April May June July August September October November December Number of Shipments 0
0 0
0 0
0 0
0 0
0 0
0 0
Volume Cu. Meter 0
0 0
0 0
0 0
0 0
0 0
0 0
Curie Content 0
0 0
0 0
0 0
0 0
0 0
0 0
Est. Total
- Error
_o N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A A
N/A Total (Type c)
_1
- d.
Other January February March April May June July August September October November December N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A Total (Type d)
Vl-3
III. RADIOACTIVE EFFLUENT RELEASES-SOLID RADIOACTIVE WASTE EFFLUENT AND WASTE DISPOSAL REPORT (continued)
B.
ESTIMATE OFMAJOR NUCLIDE COMPOSITION (By Type of Waste)
- 1.
Percentage of Curies from Represented Isotopes Isotope Percent Curies
- a.
Cs-134 46.5%
8.16E+00 All other nuclides Cs-1 37 46.1%
8.15E+00 constitute less Co-58 5.0%
8.77E-01 than 1%
Co-60 1.0%
1.79E-01
- b.
Cs-1 37 Cs-134 Ni-63 Co-60 63.4%
29.7%
3.1%
2.4%
N/A N/A 9.67R-01 4.53E-01 4.70E-02 3.62E-02 All other nuclides constitute less than 1%
c.
d.
N/A N/A N/A N/A C.
SOLID WASTE (DISPOSITION)
Number of shipments Transportation Mode 2
Closed Sole Use Vehicle 20 Closed Sole Use Vehicle Destination Barnwell, S.C.
Clive, Utah D.
IRRADIATED FUEL SHIPMENTS (DISPOSITION)
Number of Shipments Transportation Mode N/A N/A Destination N/A VIA
SECTION VII ATTACHMENT I ODCM and PCP revisions for the period January 1, 2003 through December 31, 2003 in accordance with Technical Specification 5.17.d and 5.18.d, the radioactive effluent release report shall include any revisions to the Offsite Dose Calculation Manual (ODCM) and the Process Control Program (PCP).
I revision(s) made to the Offsite Dose Calculation Manual (ODCM).
0 revision(s) made to the Process Control Program (PCP).
January 1, 2003 - December 31, 2003 VII-1